Homburger

On August 1, 2024, Miller, the leading independent specialist (re)insurance broker, announced the acquisition of the Zug-based reinsurance capital advisory business 4809 Brokers AG.The acquisition forms part of Miller’s continued international expansion and is consistent with Miller’s reinsurance strategy, which is focused on growth opportunities in the value-add and advisory parts of the market. The Homburger team was led by Daniel Hasler and Hansjürg Appenzeller (both Corporate / M&A) and included Francesco Bernasconi and Matthias Müller (both Corporate / M&A), Fabrice Eckert (Financial Market Regulation) as well as Jeremy Reichlin (Employment and Executive Compensation).  

On August 5, 2024, L'Oréal and Galderma announced the ac-quisition of a 10% stake in Galderma Group AG from Sun-shine SwissCo AG (a consortium led by EQT),Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as sellers), for a non-disclosed amount. In connection therewith, L'Oréal has agreed vis-à-vis Sunshine SwissCo AG to certain undertakings as part of a shareholders' agreement. Following the transaction, no changes to the Galderma board of directors and its governance are envisioned. In addition, L'Oréal and Galderma have agreed to work to-wards a strategic scientific partnership that will leverage the undisputed expertise of both companies: Galderma's across a broad range of dermatological solutions, and L'Oréal’s exper-tise in skin biology, diagnostic tools and evaluation methods. Homburger acted as transaction counsel to EQT. The team was led by Frank Gerhard and Margrit Marti (both Corporate / M&A, Capital Markets) and comprises Estelle Piccard, Simone Schmid and Héloïse de Jamblinne (all Corporate / M&A), Stef-an Oesterhelt (Tax), Richard Stäuber (Competition) as well as Micha Fankhauser (Financial Market Regulation).  

On August 19, 2024, Genedata AG announced that it has been acquired by Danaher Corporation (NYSE: DHR), a leading global life science and diagnostic innovator. Founded in 1997 and headquartered in Basel, Switzerland, Genedata is at the forefront of transforming data into intelligence for the life sciences industry. It delivers scalable and open solutions that enhance R&D productivity, serving top global biopharmaceutical companies and innovative biotechnology organizations around the globe. The Homburger team advising Danaher comprised Stefan Blunschi, Heinz Schärer, Oriana Schöni, Marilena Balthasar and Paula Delissen (all Corporate / M&A), Reto Heuberger and Philippe Weber (both Tax), Mariella Orelli (Litigation), Richard Stäuber (Competition) and Joel Fink (IP / IT).  

Homburger acted as counsel to ARYZTA AG in its capacity as borrower in connection with its new Swiss law governed EUR 930 m multicurrency revolving credit facility, arranged by Coöperatieve Rabobank U.A. and UBS Switzerland AG. Homburger advised ARYZTA AG with regard to all Swiss legal aspects of the financing transaction. The Homburger team included partner Claude Lambert (Corporate), counsel Eduard De Zordi and associate Stefan Bindschedler (both Financing and Investment Products) as well as partner Stefan Oesterhelt (Tax).  

Pollen Street Capital has acquired Etops Group, further consolidating the European wealthtech market by adding to its existing investments in niiio Finance Group,fundsaccess, MiFID-Recorder, and FundHero. As part of the transaction, key shareholders of Etops Group agreed to reinvest in the wider group. Pollen Street Capital is a private capital asset manager with more than GBP 4.2 bn in assets under management. Etops Group is a Swiss-based provider of software solutions and business process outsourcing services in the wealth management sector. The Homburger team advising Pollen Street Capital comprised Andreas Müller, Olivier Bühlmann, Jonas Stähli and Harun Cetin (all Corporate / M&A, Real Estate), Reto Heuberger and Philippe Weber (both Tax) and Daniel Junginger (Financing and Investment Products).  

On September 3, 2024, Raiffeisen Schweiz Genossenschaft successfully issued EUR 500 m 3.852 per cent. 8NC7 Fixed-to-Fixed Rate Bail-in Bonds due 2032. Deutsche Bank, J.P. Morgan, Morgan Stanley, Raiffeisen Schweiz Genossenschaft and UBS Investment Bank acted as Joint Lead Managers and DZ Bank and Société Générale as Co-Lead Managers. Homburger acted as counsel to Raiffeisen Schweiz Genossenschaft. The Homburger team was led by Benjamin Leisinger (Capital Markets, Financial Market Regulation) and included Sofiya Shavlak (Capital Markets) as well as Stefan Oesterhelt (Tax).  

On September 3, 2024, Sunshine SwissCo AG (a consortium led by EQT), the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd.(all acting as the Sellers) announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which lead to the successful placement of 14,273,859 shares in Galderma Group AG (Galderma) at a price of CHF 75 per share (the Placement), raising a total of ca. CHF 1.07 bn in total. The Sellers will remain shareholders of 61.21% of the share capital of Galderma. EQT’s representation on the Board of Directors of Galderma remains unchanged as a result of the Placement. Such Placement will broaden Galderma's shareholder base and free float. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma. The Placement is expected to be settled on September 6, 2024. Following the Placement, no changes to the Galderma board of directors and its governance are envisioned. Homburger acted as transaction counsel to EQT. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Lorenzo Togni (Corporate / M&A, Capital Markets), Estelle Piccard, Simone Schmid and Héloïse de Jamblinne (all Corporate / M&A), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax).  

On September 10, 2024, UBS Group AG successfully completed its offering of USD 1.5 bn of 6.850 per cent. Tier 1 Capital Notes, which are redeemable at the option of UBS Group AG after five years. The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG’s Swiss going concern requirements. Upon occurrence of a "Trigger Event" or a "Viability Event", the Notes will be converted into ordinary shares of UBS Group AG in accordance with their terms. The Notes are governed by Swiss law and have been provisionally admitted to trading, and application will be made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Benedikt Maurenbrecher and Stefan Kramer (both Capital Markets) and included Lee Saladino, Daniel Hulmann, Philipp Klein and Yulia Shaburnykova (all Capital Markets), Claude Lambert (Corporate / M&A) as well as Stefan Oesterhelt (Tax).  

On September 6, 2024, UBS Group AG successfully completed its issuance of USD 1.5 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due September 2045 under its Senior Debt Programme.The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino, Daniel Hulmann and Philipp Klein (all Capital Markets) as well as Stefan Oesterhelt (Tax).  

On September 4, 2024, Equinix, Inc., a globally leading digital infrastructure company, successfully completed its Swiss issuance of CHF 100 m 1.5575% Green Bonds due in 2029.The Bonds were issued by Equinix Europe 1 Financing Corporation LLC and are fully guaranteed by Equinix, Inc. The offering of the Bonds was done by reliance on Regulation S under the U.S. Securities Act. The net proceeds from the sale of the Bonds will be used to finance or refinance, in whole or in part, one or more eligible green projects of Equinix. Homburger advised Equinix on all Swiss law aspects of the transaction. The Homburger team was led by Alexander Wherlock (Financing and Investment Products) and included Jürg Frick (Financing and Investment Products), Sofiya Shavlak and Philipp Klein (both Capital Markets), Oliver Kneubühl (Corporate / M&A) as well as Stefan Oesterhelt (Tax).  

On September 16, 2024, Homburger filed an application with the Swiss Federal Supreme Court on behalf of U.S. Olympic gymnast Jordan Chiles to set aside an arbitral award by the Court of Arbitration for Sport (CAS). Ms. Chiles was initially awarded the Olympic bronze medal in the women's gymnastics floor exercise final at the 2024 Olympic Games after her coach's inquiry led to an increase of her final score. However, a CAS panel later determined that the inquiry was submitted four seconds past the one-minute time limit, rendering it invalid, and denied Ms. Chiles her bronze medal. In her setting-aside application, Ms. Chiles asserts that CAS violated her right to be heard by disregarding video evidence that demonstrates that the inquiry was filed within the time limit. Additionally, she contends that the CAS panel was improperly constituted because its president had a conflict of interest due to ongoing close legal ties with Romania not disclosed to Ms. Chiles during the entire CAS proceedings. The Homburger team advising Ms. Chiles is led by partner Gabrielle Nater-Bass and includes partner Stefanie Pfisterer, associates Richard G. Allemann and Frédéric Fitzi and junior associate Joël Kämpf (all Litigation / Arbitration). Homburger acts as co-counsel to international counsel to Ms. Chiles, Gibson, Dunn & Crutcher LLP.  

On September 24, 2024, Homburger filed a request for revision with the Swiss Federal Supreme Court on behalf of U.S. Olympic gymnast Jordan Chiles requesting to lift an arbitral award by the Court of Arbitration for Sport (CAS).Ms. Chiles was initially awarded the Olympic bronze medal in the women’s gymnastics floor exercise final at the 2024 Olympic Games after her coach’s inquiry led to an increase of her final score. However, a CAS panel later determined that the inquiry was submitted four seconds past the one-minute time limit, rendering it invalid, and denied Ms. Chiles her bronze medal. In her request for revision that complements her setting aside application filed on September 16, 2024, Ms. Chiles asserts that video evidence that has emerged in the meantime demonstrates that the inquiry was filed within the time limit. The Homburger team advising Ms. Chiles is led by partner Gabrielle Nater-Bass and includes partner Stefanie Pfisterer, associates Richard G. Allemann, Frédéric Fitzi and Ramona Keist and junior associate Joël Kämpf (all Litigation / Arbitration). Homburger acts as co-counsel to international counsel to Ms. Chiles, Gibson, Dunn & Crutcher LLP.  

On September 18, 2024, Sulzer AG successfully priced the offering of its CHF 250 m 1.7725% bonds. Zürcher Kantonalbank and Commerzbank Aktiengesellschaft acted as managers. The bonds will be listed on the SIX Swiss Exchange. Homburger acted as counsel to Sulzer AG. The Homburger team consisted of Benjamin Leisinger and Eduard De Zordi (both Capital Markets).  

On October 1, 2024, Swiss Life Finance II AG successfully completed its issuance of EUR 500 m 4.241% callable subordinated capital securities 2024–2044 (the Bonds). The Bonds are governed by Swiss law and will be listed on the SIX Swiss Exchange. The Bonds are irrevocably guaranteed on a subordinated basis by Swiss Life AG and Swiss Life Holding AG. Homburger advised the Joint-Lead Managers (UBS Investment Bank, Deutsche Bank AG, J.P. Morgan and Natixis) in respect of aspects of Swiss law. The Homburger team was led by Benjamin Leisinger and included Sofiya Shavlak and Daniel Hulmann (all Capital Markets) as well as Dieter Grünblatt (Tax).  

Homburger advised TowerBrook Capital Partners, a London and New York-based investment company, on its acquisition of a majority stake of the IDAK Food Group. The management team of IDAK Food Group retains a minority stake. IDAK Food Group is a strongly networked group of specialized companies and manufacturers in the premium frozen food sector. The Homburger team was led by Anna Peter (Corporate / M&A) and Jürg Frick (Financing and Investment Products) and included Héloïse de Jamblinne, Alessandra Dumitru and Carolina Rodriguez (all Corporate / M&A), Nathalie Scherrer (Financing and Investment Products), Reto Heuberger and Juliette Buob (all Tax) as well as Richard Stäuber, Andreas Burger and Christoph Grüninger (all Regulatory).  

On September 23, 2024, UBS Switzerland AG successfully completed its issuance of EUR 1 bn Fixed Rate Covered Bonds due September 23, 2027 under its Covered Bond Programme. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG’s domestic mortgage pool. Homburger advised UBS Switzerland AG as issuer and UBS Hypotheken Schweiz AG as guarantor in respect of all transactional, regulatory and tax aspects of Swiss law. The Homburger team was jointly led by Stefan Kramer and Benedikt Maurenbrecher and included Daniel Hulmann, Yulia Shaburnykova and Caroline Grand (all Capital Markets) as well as Stefan Oesterhelt (Tax).  

Central Group acquires the operational business of Magazine zum Globus, which operates luxury department stores in Switzerland. The business is acquired from the insolvent Signa group. Homburger advised Central Group on all Swiss law aspects, including Swiss insolvency law aspects, of the transaction. The Homburger team was led by Jürg Frick (Financing and Investment Products, Real Estate) and Miguel Sogo (Litigation, Restructuring / Insolvency) and included Richard Stäuber (Competition, Regulatory), Nathalie Scherrer (Financing and Investment Products, Corporate / M&A), Oliver Mrose (Litigation, Restructuring / Insolvency), Joel Kämpf (Litigation), Céline Ruegg (Competition, Regulatory). October 3, 2024 Contact Nanding Susso / Marketing / [email protected]

Following the successful offering and issuance of EUR 380 m 8.250% senior secured notes due 2028 and GBP 475 m 10.000% senior secured notes due 2028 by Pinnacle Bidco plc,the parent company of PureGym Limited, on October 11, 2023, on September 27, 2024, Pinnacle Bidco plc completed the sale and issuance of privately-placed EUR 125 m 8.250% senior secured notes due 2028 and GBP 45 m 10.000% senior secured notes due 2028. PureGym is a leading European gym operator, with 1.9 m members across approximately 550 sites in its key markets (United Kingdom, Denmark and Switzerland). The Homburger team was led by Jürg Frick (Financing and Investment Products) and included Alexander Wherlock and Sarah Fasel (both Financing and Investment Products) as well as Stefan Oesterhelt (Tax).  

Homburger acted as counsel to Deutsche Bank AG, London Branch, in respect of a syndicated German law bridge financing for VARTA AG, which allows VARTA AG to secure key liquidity to complete its ongoing restructuring measures under the German StaRUG (German Act on the Stabilisation and Restructuring Framework for Companies). The bridge financing is a crucial part of the measures intended to secure VARTA AG's core electronic battery industry, thereby helping to safeguard jobs and value creation in Germany and Switzerland. VARTA AG produces and markets a diverse range of batteries including micro batteries, household batteries, energy storage systems and customer-specific battery solutions. As technology leader, VARTA AG sets industry standards in important areas of the battery technology field. Homburger advised Deutsche Bank AG, London Branch, and the other syndicate banks with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick (Financing and Investment Products) and included Sarah Fasel and Nathalie Scherrer (both Financing and Investment Products) as well as Stefan Oesterhelt (Tax).  

On October 24, 2024, Avolta AG announced that it concluded the refinancing of its revolving credit facility (RCF). The amended EUR 2,400 m RCF with maturity in 2029 replaces the EUR 2,750 m RCF expiring in 2027. Homburger acted as counsel to Avolta. The Homburger team included Jürg Frick and Nathalie Scherrer (both Financing and Investment Products), Andreas Müller (Corporate / M&A) and Stefan Oesterhelt (Tax).  

The Hevolution Foundation and other investors provided additional funding in a Series A round totaling USD 30.7 m. Vandria discovers and develops novel small molecules that induce mitophagy to treat in particular age-related and chronic diseases. Hevolution Foundation is a global non-profit organization that provides grants and early-stage investments to incentivize independent research and entrepreneurship in the emerging field of health span science. The Homburger team advising Hevolution Foundation included Andreas Müller and Marc Abplanalp (both Corporate / M&A), Luca Dal Molin and Joel Fink (both IP / IT) and Jeremy Reichlin (Employment and Executive Compensation).  

On October 7, 2024, MYT Netherlands Parent B.V. (Mytheresa) announced that it has entered into a definitive agreement with Compagnie Financière Richemont SA (Richemont) to acquire YOOX NET-A-PORTER (YNAP) in exchange for a 33% equity stake in Mytheresa. YNAP will contribute to MyTheresa's aim to become a leading, global, multi-brand digital luxury group offering a highly curated and strongly differentiated edit of the most prestigious luxury brands and products to luxury enthusiasts worldwide. The acquisition will be completed in the first half of 2025 after receiving all required regulatory approvals. Homburger advised MyTheresa on the Swiss aspects of the transaction. The Homburger team advising MyTheresa was led by Daniel Hasler and included Jonas Stähli and Felix Beltle (all Corporate / M&A) as well as Allegra Arnold (Competition).  

On October 16, 2024, Liberty Global Ltd. (NASDAQ: LBTYA, LBTYB and LBTYK) and Sunrise Communications AG (Sunrise) announced the key dates of the spin-off of Sunrise from Liberty Global.After the spin-off, Sunrise, which is Switzerland's largest private telecommunications provider, will be an independent, separate publicly traded Swiss company. As part of the spin-off, Liberty Global shareholders will receive Sunrise Class A shares and Sunrise Class B shares in the form of Sunrise Class A ADSs and Sunrise Class B ADSs. The Sunrise Class A shares will be listed on the SIX Swiss Exchange (SIX) and the Sunrise Class A ADSs will be listed on the Nasdaq Global Select Market (NASDAQ). The spin-off is subject to approval by Liberty Global's shareholders. The first day of trading on the NASDAQ and the SIX is scheduled for November 13 and 15, 2024, respectively. Homburger AG acts as Swiss counsel to Liberty Global and Sunrise. The Homburger team is led by Daniel Daeniker and Daniel (Danny) Häusermann and includes, among others, Carlo Sulser, Patrick Schmidt, Michael Lüchinger, Marilena Balthasar, Felix Beltle and Paula Delissen (all Corporate / M&A, Capital Markets), Stefan Oesterhelt, Laetitia Fracheboud, Juliette Buob and Tanja Niederer (all Tax), Andreas Müller, Jeremy Reichlin and Daniel Bötticher (all Employment and Executive Compensation), Richard Stäuber and Christoph Grüninger (all Competition, Regulatory), Gabriel Kasper (IP / IT), Sarah Fasel (Financing and Investment Products) and Daniel Junginger (Real Estate).  

Homburger acted as counsel to SMBC Group in its capacity as documentation agent in connection with an English law-governed JPY 42,000 m (around CHF 250 m)sustainability-linked Samurai loan with Axpo Holding AG as borrower and an international syndicate of banks as lenders for the financing of Axpo's business development in fields such as renewable energy in Switzerland and abroad. The Homburger team comprised Jürg Frick and Nathalie Scherrer (both Financing and Investment Products) and Stefan Oesterhelt (Tax).  

On October 24, 2024, HANetf ETC Securities plc, an Irish public limited company successfully listed its The Royal Mint Responsibly Sourced Physical CHF Hedged Gold ETC Securities (RMCH), ISIN being XS2892962718, issued under its metal securities programme for Exchange Traded Products, on the SIX Swiss Exchange. Homburger advised HANetf ETC Securities plc on this transaction with respect to aspects of Swiss law and regulations, including listing regulations. The Homburger team comprised Benjamin Leisinger, Sofiya Shavlak and Yulia Shaburnykova (all Capital Markets and Financing and Investment Products).  

On October 25, 2024, Molecular Partners AG, a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics announced that it had priced an underwritten offering of 3,642,988 American Depositary Shares (ADSs) representing 3,642,988 new shares at an offering price of USD 5.49 per ADS amounting to gross proceeds of USD 20 m. The offering included participation from a new investor HBM Healthcare Investments Ltd, which is a leading healthcare investor, as well as multiple existing investors. Molecular Partners currently intends to use the net proceeds from this offering for the development and expansion of its radiopharmaceutical pipeline and platform (Radio-DARPin Therapeutics) and other general corporate purposes. The Homburger team was led by Dieter Gericke and Karin Mattle (both Corporate / M&A, Capital Markets) and included Stefan Oesterhelt (Tax), Lorenzo Togni, Romain Fakhoury and Hans Glent Abildgaard (all Corporate / M&A, Capital Markets).  

On August 13, 2024, Elanco Animal Health Incorporated and Elanco US Inc. entered into an incremental assumption agreement to obtain an incremental term facility. The granting of the comprehensive security package involving various jurisdictions was completed on September 9, 2024. Homburger advised the Elanco entities incorporated in Switzerland with any aspects of Swiss law with the transaction. The Homburger team was led by Daniel Haeberli and included Simone Gloor and Julia Koch (all Financing) as well as Stefan Oesterhelt (Tax).  

Homburger acted as counsel to UBS Switzerland AG as mandated lead arranger, underwriter, agent,security agent and original lender in connection with the financing of the acquisition of IMPAG Group by Deutsche Private Equity (DPE). IMPAG, headquartered in Zurich and with subsidiaries in Switzerland, Germany, Poland, France, Austria and Spain, is an internationally orientated value-added specialty chemical distribution company that supplies and supports the life science and material science industries in Europe with raw materials, active ingredients and services. Homburger advised UBS Switzerland AG and the other syndicate banks with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick (Financing) and included Stefan Bindschedler, Nathalie Scherrer, Sarah Fasel and Michelle Wolf (all Financing) as well as Stefan Oesterhelt (Tax).  

The Kellenberger family has significantly reduced its shareholding in Calida Holding AG (the Company) in two transactions, a public buy-back offer and a direct repurchase. Homburger advised the Kellenberger family on these transactions. The Homburger team was led by Dieter Gericke and included Hansjürg Appenzeller, Daniel Häusermann, Cédric Berger, Thierry Burckhardt, Caspar Wehrle and Marc Abplanalp (all Corporate / M&A) as well as Reto Heuberger, Arbnor Sheholli and Philipp Stiegeler (all Tax).  

On October 30, 2024, Viseca Payment Services AG successfully completed its issuance of CHF 150 m 1.350 per cent. bonds due 2029.Raiffeisen Schweiz Genossenschaft, UBS AG and Zürcher Kantonalbank acted as Joint Lead Managers. The Homburger team was led by Benjamin Leisinger and included Daniel Hulmann (both Capital Markets).  

Homburger acts as counsel to SIX Group AG in connection with the contemplated acquisition of Aquis Exchange Plc, which was announced on November 11, 2024.SIX Group AG operates a fully integrated exchange value chain across the Swiss and Spanish financial centres, thus ensuring access to the capital markets and the flow of information and money between financial market players. Aquis Exchange Plc is Europe's challenger exchange, creating better markets for a modern economy. Aquis Exchange Plc has market-leading technology and innovative rules for trading, and offer primary listings and secondary trading of equities, along with global licensing of proprietary technology. Homburger advises SIX Group AG with regard to all Swiss legal aspects of the acquisition. The Homburger team is co-led by Jürg Frick and Stefan Kramer (both Banking / Finance) and includes Benjamin Leisinger, Stefan Bindschedler, Alexander Wherlock, Sofiya Shavlak and Riccardo Pompeo (all Banking / Finance) as well as Stefan Oesterhelt (Tax).  

In July 2024, Alchemy US Holdco 1, LLC renewed its credit financings and entered into a term loan credit agreement with HPS Investment Partners,LLC as term loan agent and an ABL credit agreement with KeyBank National Association as ABL agent and joint collateral agent. The accession of Alchemy Transatlantic-S GmbH and the granting of the comprehensive security package involving various jurisdictions was completed in October 2024. Homburger advised Alchemy on all aspects of Swiss law with the transaction. Alchemy produces non-ferrous metal powders, with a focus on copper and aluminum powder, serving diverse end-markets including chemicals, automotive, and industrial sectors worldwide. The Homburger team was led by Daniel Haeberli and included Simone Gloor and Manuel Adassery (all Financing) as well as Stefan Oesterhelt (Tax).  

On November 20, 2024, Sunshine SwissCo AG (a consortium led by EQT), the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers)announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 16,000,000 shares in Galderma Group AG (Galderma) at a price of CHF 80 per share (the Placement), raising a total of ca. CHF 1.28 bn in total. The Sellers will remain shareholders of 54.48% of the share capital of Galderma. EQT’s representation on the Board of Directors of Galderma remains unchanged as a result of the Placement. Such Placement will broaden Galderma's shareholder base and free float. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma. The Placement is expected to be settled on November 25, 2024. Following the Placement, no changes to the Galderma board of directors and its governance are envisioned. Homburger acted as transaction counsel to EQT. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Lorenzo Togni, Estelle Piccard and Héloïse de Jamblinne (all Corporate / M&A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax).  

On December 2, 2024, Bank J. Safra Sarasin AG announced the acquisition of 100% of the shares of MIV Asset Management AG ("MIV"). MIV is characterized through its investments in medical technology and its flagship fund, the MIV Global Medtech Fund. MIV is known for its innovative approach and in-depth knowledge of the sector. MIV's offering is an addition to Bank J. Safra Sarasin's range of thematic equity strategies, which are available to both private and institutional investors. MIV's investment strategy and organizational structure will remain unchanged to ensure solid performance and seamless client service. The Homburger team advising the selling shareholders was led by Daniel Hasler and Daniel Daeniker and included Stefan Blunschi, Caspar Wehrle, Bianca Nedwed and Felix Beltle (all Corporate / M&A), Marc Bircher (Litigation), Jürg Frick and Philipp Klein (both Financial Market Regulation), Stefan Oesterhelt, Peter Müller and Philipp Stiegeler (all Tax) as well as Jeremy Reichlin (Employment and Executive Compensation).  

On December 11, 2024, Noema Pharma AG announced that it has successfully closed a Series B extension financing round with an investment from EQT Life Sciences,bringing the total capital raised in the round to CHF 130 m (approx. USD 147 m). With its investment in Noema Pharma, EQT Life Sciences joins the syndicate of previous Series B investors including Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus and UPMC Enterprises. Noema Pharma is a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders characterized by imbalanced neuronal networks. The new financing will support Noema Pharma's four active Phase 2 trials, with key data readouts anticipated in 2025. Homburger AG advised Noema Pharma AG as transaction counsel in this Series B extension financing round. The Homburger team comprised Andreas Müller, Thierry Burckhardt, Thomas Romelli and Rebecca Sigrist (all Corporate / M&A; Healthcare / Life Sciences), Luca Dal Molin (IP / IT; Healthcare / Life Sciences) as well as Stefan Oesterhelt and Laetitia Fracheboud (Tax).  

Homburger acted as counsel to UBS Switzerland AG in its capacity as mandated lead arranger,sole bookrunner and original lender in connection with two Swiss law-governed revolving credit facilities agreements in an aggregate volume of CHF 3.6 bn with Alpiq Holding AG as borrower and an international syndicate of banks as lenders for, inter alia, the groups’ liquidity needs. The Homburger team comprised Jürg Frick and Nathalie Scherrer (both Financing and Investment Products) and Stefan Oesterhelt (Tax).  

On December 27, 2024, Yoda PLC, a Cyprus-based investment corporation listed on the Cyprus stock exchange (CSE: YODA), announced the completion of its major investment into ULTIMA CAPITAL SA (Ultima), a Swiss luxury real estate owner, developer and operator listed on BX Swiss (BX: ULTIMA). As part of the transaction, Yoda has transferred to Ultima, by way of a contribution in kind, 100% of the issued share capital of its wholly-owned subsidiary Papacamp Investments Limited (Papacamp) at a contribution value of approximately CHF 484.6 m in return for 8,076,667 newly-issued shares of Ultima. Papacamp indirectly owns real estate properties and real estate developments in Greece within the luxury hospitality sector. As a result of the transaction, Yoda has become Ultima's largest shareholder, with a shareholding interest in Ultima of approximately 53.8%. In addition, Yoda has granted Ultima a loan in the amount of CHF 71 m. The Homburger team advising Yoda on all aspects of the transaction was led by Stefan Blunschi and included Micha Fankhauser, Oliver Kneubühl, Jonas Stähli and Leander Etter (all Corporate / M&A), Lorenzo Togni and Kaiyan Yeo (both Capital Markets), Claudia Suter, Philippe Weber and Philippe Gobet (all Tax), Stefan Bindschedler and Nathalie Scherrer (both Financing and Investment Products), Stefan Gäumann and Olivier Bühlmann (both Real Estate), and Richard Stäuber and David Thomann (both Regulatory).  

On December 18, 2024, Novo Nordisk announced that it has successfully completed its USD 11 bn acquisition of three manufacturing sites from Novo Holdings A/S. The completion follows the finalization of Novo Holdings' acquisition of Catalent, Inc., a global contract development and manufacturing organization. The three acquired sites are specialized in the sterile filling of drugs and are located in Anagni (Italy), Brussels (Belgium) and Bloomington IN (USA). Novo Nordisk is a leading global healthcare company headquartered in Denmark. Its purpose is to drive change to defeat serious chronic diseases, built upon its heritage in diabetes. Catalent is a global contract development and manufacturing organization headquartered in Somerset, New Jersey. The company has over 50 global sites and employs more than 18,000 people. A Homburger team comprising Andreas Müller, Anna Peter, Simone Schmid, Bianca Nedwed, Florian Bruggisser and Maria Braun (all Corporate / M&A), Allegra Arnold, Meret Horisberger and Harun Cetin (all Regulatory), Jeremy Reichlin (Employment) as well as Reto Heuberger, Juliette Buob and Philipp Stiegeler (all Tax) advised Novo Nordisk on the transaction.  

On January 10, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases,announced its launch with a USD 200 m series A financing from lead investors OrbiMed, Novo Holdings and Blue Owl Healthcare Opportunities, and co-investors SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital and Pivotal bioVenture Partners. Windward Bio has entered into an agreement to license WIN378, a potential best-in-class, long-acting monoclonal antibody targeting the ligand of thymic stromal lymphopoietin (TSLP), from Kelun-Biotech and Harbour BioMed for global rights, excepting China and select smaller markets in Asia. Proceeds from the financing will be used to develop a phase 2-ready, long-acting anti-TSLP antibody with best-in-class potential in asthma and chronic obstructive pulmonary disease (COPD). Homburger AG advises Windward Bio on its set-up and financing. The Homburger team comprises Andreas Müller, Margrit Marti, Oliver Kneubühl, Kaiyan Yeo, Eric Huber, Jonas Stähli, Rebecca Sigrist and Carolina Rodriguez (all Corporate / M&A), Stefan Oesterhelt and Juliette Buob (both Tax) and Luca Dal Molin (IP / IT).  

Homburger acted as counsel to UBS Switzerland AG as mandated lead arranger, coordinator, agent, security agent and original lender in connection with the refinancing of the Sequotech Group, an IT services group owned by multi-family office Verium AG and Sequotech’s management team. Homburger advised UBS Switzerland AG, Migros Bank AG and Zürcher Kantonalbank with regard to all legal aspects of the financing transaction. The Homburger team was led by Jürg Frick and included Nathalie Scherrer and Jannis Zafeirakos (all Financing and Investment Products) as well as Stefan Oesterhelt (Tax).   Contact Nanding Susso / Marketing / [email protected]

On June 2, 2025, Temenos announced that it has completed the sale of Multifonds, its fund administration software business, to Montagu Private Equity. The Homburger team was led by Dieter Gericke and Daniel Häusermann (both Corporate / M&A) and included Nicola Togni, Romain Hondius, Thomas Romelli, Luca Ellenberger, Miriam Oelgarth and Myriam Amman-Jerdak (all Corporate / M&A), Gregor Bühler, Philippe Baumann and Kristina Martinovic (all IP / IT), Stefan Oesterhelt, Laetitia Fracheboud and Juliette Buob (all Tax) as well as Richard Stäuber and Christoph Grüninger (both Competition). Contact Johanna Schmid / Marketing / [email protected]

On January 29, 2025, BioVersys AG, a clinical-stage biopharmaceutical company developing and commercializing novel antibacterial products for life-threatening infections domiciled in Basel, Switzerland, announced the launch of its Initial Public Offering (IPO) on SIX Swiss Exchange, the publication of the offer price and the start of the bookbuilding process. The IPO comprises a primary offering targeting gross proceeds of CHF 80 m (including an over-allotment option targeting gross proceeds of CHF 5 m). The implied market capitalization of the company, assuming all offered shares are sold in the IPO and the over-allotment option is exercised in full, is approximately CHF 212.9 m. The first day of trading is expected to be February 7, 2025. BioVersys focuses on identifying, developing and commercializing novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The Company's most advanced R&D programs address nosocomial pneumonia and blood stream infections caused by Acinetobacter baumannii (BV100, phase 3-ready) and tuberculosis (alpibectir, phase 2a). In addition to its domicile in the biotech hub in Basel, Switzerland, BioVersys has operations in in Lille, France, Delaware, United States and Guangzhou, China. Citigroup Global Markets Limited, UBS AG and Stifel Europe AG are acting as Joint Global Coordinators and Joint Bookrunners on the IPO, Mirabaud & Cie SA and Octavian AG as Selling Agents. Homburger is advising BioVersys on all aspects of the IPO as lead counsel. The Homburger team is co-led by Dieter Gericke and Lorenzo Togni and includes Thierry Burckhardt, Magda Aref, Simone Schmid, Raphael Linder, Harun Cetin and Leander Etter (all Corporate / M&A and Capital Markets). Luca Dal Molin and Kristina Martinovic (both IP / IT) are providing intellectual property advice, Jeremy Reichlin (Employment and Executive Compensation) is providing employment and executive compensation advice, and Reto Heuberger and Philippe Weber (both Tax) are providing tax advice.  

On February 5, 2025, Luzerner Kantonalbank successfully priced its issuance of CHF 150 m 3.00% Additional Tier 1 Bonds by Luzerner Kantonalbank.The issuance is expected to close on February 28, 2025. Zürcher Kantonalbank acted as Structuring Advisor and Joint-Lead Manager and Luzerner Kantonalbank and UBS AG acted as Joint-Lead Managers. The Homburger team was led by Benjamin Leisinger and included Olivier Baum (both Capital Markets) as well as Dieter Grünblatt (Tax).  

On January 30, 2025, Matterhorn Telecom S.A., the parent company of Salt Mobile SA, issued EUR 420 m 4.500% Senior Secured Notes due 2030 guaranteed by Matterhorn Telecom Holding S.A. and Salt Mobile SA.Homburger acted as Swiss counsel to a syndicate of initial purchasers led by Goldman Sachs International, BofA Securities Europe SA, BNP Paribas, Crédit Agricole Corporate and Investment Bank, J.P. Morgan SE, Société Générale and UBS AG London Branch. In addition, Homburger acted as Swiss counsel to Goldman Sachs International in its capacity as new facility B3 lender and mandated lead arranger in connection with Matterhorn Telecom S.A.'s new EUR 430 m English law governed term loan facility. Homburger advised Goldman Sachs International and the other syndicate banks with regard to all Swiss law aspects of the new term loan B3 facility. The Homburger team was led by Jürg Frick (Financing and Investment Products) and included Eduard De Zordi (Capital Markets), Olivier Baum (Capital Markets, Financing and Investment Products) as well as Stefan Oesterhelt (Tax).  

On February 19, 2025, Julius Baer Group Ltd. successfully issued USD 400 m of 7.5% Perpetual Tier 1 Subordinated Contingent Convertible Bonds (Tier 1 CoCos). The Tier 1 CoCos and all transaction documents are governed by Swiss law. If a trigger event occurs and is continuing on the relevant subsequent trigger test date or if a viability event has occurred, a contingent conversion of the Tier 1 CoCos will occur on the relevant conversion settlement date into shares of Julius Baer Group Ltd. issued out of its conversion capital introduced by the shareholders at the occasion of the annual shareholders meeting in 2024. The Tier 1 CoCos feature a denomination of USD 200k each. The Tier 1 CoCos have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing, on the SIX Swiss Exchange. Homburger advised Julius Baer Group Ltd. with respect to all regulatory, transactional and tax aspects of Swiss law. The Homburger team was co-led by Benjamin Leisinger (Capital Markets, Financial Market Regulation) and Eduard De Zordi (Capital Markets), and included Yulia Shaburnykova (Capital Markets), as well as Dieter Grünblatt (Tax) and Claude Lambert (Corporate / M&A).  

On February 12, 2025, HomeToGo SE (Frankfurt Stock Exchange: HTG) announced the signing of a binding agreement to acquire Interhome, Europe's second largest vacation rental management company, from Migros, Switzerland’s largest retail company. HomeToGo agreed to a purchase price of CHF 150 m, plus deferred payments of up to CHF 85 m which may become due in tranches until 2029, making this the most significant transaction in HomeToGo Group's history and positioning HomeToGo to become Europe's leading vacation rental platform. With this transaction, HomeToGo Group's total pro-forma Adjusted EBITDA for FY/24e would triple to more than EUR 30 m. The transaction is expected to be financed through a combination of new equity, senior debt and available net cash and is expected to close in H1/25, subject to customary regulatory approvals for both the acquisition of Interhome by HomeToGo and the simultaneous acquisition - in the same transaction - of the other entities in Hotelplan Group by DERTOUR Group, a renowned international tourism group. Homburger advises HomeToGo on the Swiss law and tax aspects of the transaction. The Homburger team was led by Frank Gerhard (Corporate / M&A) and included Olivier Bühlmann, Magdalena Stock, Daniel Bötticher, Miriam Oelgarth and Harun Cetin (all Corporate / M&A), Stefan Bindschedler and Michelle Wolf (both Financing and Investment Products), Luca Dal Molin and Joel Fink (both IP / IT), Richard Stäuber and Christoph Grüninger (both Competition), Reto Heuberger, Stefan Oesterhelt and Philippe Weber (all Tax), Vanessa Huber and Jeremy Reichlin (both Employment and Executive Compensation), Gabriel Kasper (Data Protection) as well as Stefanie Pfisterer (Arbitration). Homburger acted alongside a German-based Linklaters team on this transaction.  

On February 24, 2025, SIX-listed Swiss Prime Site AG (Ticker: SPSN) announced the launch of an accelerated bookbuild offering,which led to the successful placement of 2,926,829 newly issued shares at a placement price of CHF 102.50 each, raising aggregate gross proceeds of approximately CHF 300 m. The offering was conducted by way of private placements (i) exclusively to professional investors in Switzerland, (ii) outside Switzerland and the United States to qualified investors in reliance on Regulation S under the U.S. Securities Act and other applicable securities laws and (iii) in the United States to qualified institutional buyers in reliance on Rule 144A under the U.S. Securities Act. The first day of trading of the new shares on the SIX Swiss Exchange is expected to be February 26, 2025. Closing is expected to take place on February 27, 2025. Swiss Prime Site intends to use the net proceeds from the offering for property acquisitions within the next 9-12 months and for general corporate purposes. Citigroup Global Markets Limited and UBS AG are acting as Joint Global Coordinators and Joint Bookrunners in connection with the offering. Homburger advises Swiss Prime Site AG on all aspects of the transaction. The Homburger team is led by Daniel Hasler (Corporate / M&A, Capital Markets) and Lorenzo Togni (Capital Markets) and includes Olivier Baum (Capital Markets) and Yannick Reber (Corporate / M&A). Stefan Oesterhelt (Tax) provides tax advice.  

On February 26, 2025, Idorsia Ltd announced that it has reached an agreement with more than two-thirds of its convertible bondholders – a majority sufficient to pass resolutions at the relevant bondholders’ meetings – to restructure its outstanding convertible bond debt. The agreement includes a tailored restructuring of Idorsia’s total CHF 800 m convertible bond debt and a CHF 150 m new money facility, enabling the company’s continued operations. As a first step of the restructuring, a bondholders’ meeting was held on February 25, 2025 to approve the extension of the maturity of the convertible bond 2025 (CB2025) until September 17, 2025. In a second step, Idorsia intends to call bondholders’ meetings to amend the terms of both the CB2025 and the convertible bond 2028 (CB2028) to, among others, extend the maturity date by 10 years, subject to the approval by the relevant court. In a third step, a special purpose vehicle (SPV) will be created. Idorsia intends to transfer to this SPV its rights to selatogrel and cenerimod, and its rights to aprocitentan. A bond exchange offer will be launched by the SPV, where the CB2025 and CB2028 bondholders will be offered the opportunity to exchange their convertible bonds for newly created notes issued by the SPV. For participating in the exchange offer, bondholders will be entitled to receive up to a total of 8.04 m Idorsia shares and up to a total of 8.04 m Idorsia warrants. Any potential net payments for milestones and royalties from selatogrel and cenerimod, as well as any potential net proceeds from a deal for aprocitentan will be used to repay holders of the SPV notes. Idorsia’s rights to all three products will return to Idorsia once the SPV notes have been fully paid. In addition to the holistic restructuring, Idorsia has secured a new money facility for a net amount of CHF 150 m that will extend Idorsia’s cash runway into 2026. This new money facility will be repaid within 24 months and is fully backstopped by a bondholder group who will receive a total of 9.0 m Idorsia shares and 8.0 m Idorsia warrants. All bondholders will also be invited to participate in this new money facility. Those bondholders participating in the new money facility will be entitled to receive up to a total of 10.5 m Idorsia shares and up to 9.5 m Idorsia warrants. In addition, they will receive in the bond exchange offer in return (up to a certain amount) SPV notes which are repaid first. Finally, all bondholders will be offered the opportunity to participate in the binding lock-up agreement in return for a 1% capitalized fee. The restructuring and financing measures are expected to significantly strengthen Idorsia’s financial position, allowing the company to advance its business strategy and create long-term value for stakeholders. Homburger advises Idorsia Ltd as lead corporate, restructuring and capital markets counsel. The Homburger team is led by Frank Gerhard (Corporate / M&A) and includes Eduard De Zordi (Capital Markets), Marco Rostetter (Corporate / M&A, Restructuring / Insolvency), Estelle Piccard and Daniel Hulmann (Corporate / M&A, Capital Markets), Miguel Sogo (Litigation, Restructuring / Insolvency), Stefan Oesterhelt (Tax), Jeremy Reichlin (Employment, Restructuring / Insolvency) and Oliver Mrose (Litigation, Restructuring / Insolvency) as well as Rebecca Sigrist (Corporate / M&A) and Syra Angliker (Litigation, Restructuring / Insolvency). Contact Nanding Susso / Marketing / [email protected]

IonQ, Inc., a leading commercial quantum computing and networking company, announced on May 6, 2025, the completion of its acquisition of a controlling stake in Geneva-based ID Quantique SA, a global leader in quantum-safe networking and quantum detection systems, from SK Telecom, the largest wireless telecommunications operator in South Korea. This strategic step strengthens IonQ's leadership in end-to-end quantum solutions and expands its global footprint in secure communications. Homburger advised IonQ as Swiss counsel on the transactions. The Homburger team included David Oser and Anna Peter (co-lead) (both Corporate / M&A), Margrit Marti, Héloïse de Jamblinne, Thomas Romelli, Erik Habich and Leander Etter (all Corporate / M&A), Joel Fink (IP / IT), Laetitia Fracheboud (Tax) and Jeremy Reichlin (Employment). Contact Nanding Susso / Marketing / [email protected]

On May 6, 2025, OC Oerlikon announced that it has signed a definitive agreement for the divestment of its Barmag textile machinery business for manmade fibers to Rieter at an enterprise value of CHF 850 m with an earn-out of up to CHF 100 m. Upon closing of this transaction, Oerlikon will become a distinct global pure-play surface technology company, serving a broad base of customers in demanding industries – from automotive, aerospace and energy to luxury, medical, defense and semiconductors – with a toolbox of high-tech surface technologies. The Homburger team is led by Daniel Hasler (Corporate / M&A) and includes Anna Peter, Nicola Togni, Simone Schmid, Oliver Kneubühl, Matthias Müller, Yannick Reber, Fabio Gasser and Raphael Linder (all Corporate / M&A), Dieter Grünblatt and Peter Müller (both Tax), Richard Stäuber and Nicolas Stocker (both Competition), Lorenzo Togni (Capital Markets) as well as Jürg Frick (Financing and Investment Products). Contact Nanding Susso / Marketing / [email protected]

Homburger advised the syndicate banks in connection with the refinancing of gategroup, a global food and hospitality company and the world’s market-leading inflight caterer. The refinancing consisted of a EUR 675 m term loan, a USD 500 m term loan and a CHF 300 m multicurrency revolving credit facility. Homburger acted as counsel to the syndicate banks with regard to all Swiss legal aspects of the refinancing transaction. The Homburger team was led by Stefan Bindschedler (Financing and Investment Products) and included Jürg Frick and Jannis Zafeirakos (both Financing and Investment Products) as well as Stefan Oesterhelt (Tax). Contact Beatrice Winkler / Marketing / [email protected]

On May 14, 2025, Raiffeisen Schweiz Genossenschaft successfully completed its issuance of CHF 170 m 0.85 per cent. fixed rate senior bonds due 2029, and CHF 310 m 1.1875 per cent. fixed rate senior bonds due 2032. Raiffeisen Schweiz Genossenschaft acted as Lead Manager and BNP Paribas, Deutsche Bank and UBS Investment Bank acted as Managers. Homburger acted as counsel to Raiffeisen Schweiz Genossenschaft. The Homburger team was led by Benjamin Leisinger and included Olivier Baum (both Capital Markets). Contact Johanna Schmid / Marketing / [email protected]

On March 10, 2025, Sunshine SwissCo GmbH (a consortium led by EQT), the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers) announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 15,000,000 shares in Galderma Group AG (Galderma) at a price of CHF 89 per share (the Placement), raising a total of ca. CHF 1.335 bn in total. The Sellers will remain shareholders of 48.18% of the share capital of Galderma. EQT’s representation on the Board of Directors of Galderma remains unchanged as a result of the Placement. Such Placement will broaden Galderma’s shareholder base and free float. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma. The Placement settled on March 13, 2025. Following the Placement, no changes to the Galderma board of directors and its governance are envisioned. Homburger acted as transaction counsel to EQT. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Margrit Marti, Estelle Piccard, Héloïse de Jamblinne and Lucas Forrer (all Corporate / M&A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On May 6, 2025, Samaplast AG, a privately held Swiss company, announced that 100% of its shares had been acquired by a group of investors led by Philipp Looser. Samaplast is a leading specialist in the field of plastics processing for medical technology and industry. The Homburger team advising the selling shareholders was led by Daniel Häusermann (Corporate / M&A) and included Matthias Müller (Corporate / M&A), Allegra Arnold (Competition), Philippe Weber (Tax) and Leon Indov (Corporate / M&A). Marcel Dietrich acted as senior relationship partner. Contact Nanding Susso / Marketing / [email protected]

On March 5, 2025, the Swiss Shakti Foundation, a foundation (Stiftung) operating under the laws of Switzerland, established its SXE Digital SMART Note Issuance Program. The notes issued under the SXE Digital SMART Note Issuance Program (the Notes) will be issued as ledger-based securities (Registerwertrechte) within the meaning of article 973d of the Swiss Code of Obligations. The terms and conditions of the Notes and the applicable tokenization terms (Registrierungsvereinbarung) are governed by Swiss law. The proceeds (after deduction of the fees, costs and expenses incurred by the Issuer in connection with such issuance) from the issuance of each tranche of Notes will, in an amount of 90%, serve as collateral for the investors and, in an amount of 10%, be used for the furtherance of the "Project". The Project is a unique program (which was gifted by the Swiss Shakti Foundation's founder) that addresses school participation deficits globally by utilizing a Proof-of-Effort (PoE) blockchain protocol where parents and guardians are incentivized to bring and send their children to school by receiving one native digital cryptocurrency Shakti Coin for each child, every day the child attends school. The base prospectus for the SXE Digital SMART Note Issuance Program has been approved by the Prospectus Review Office of BX Swiss AG in its capacity as review body pursuant to article 52 of the FinSA on March 5, 2025. The Homburger team was led by Benjamin Leisinger (Capital Markets, Financing and Investment Products) and included Lee Saladino (Capital Markets) as well as Alexander Wherlock (Financial Market Regulation, Financing and Investment Products). Contact Nanding Susso / Marketing / [email protected]

In December 2024, UBS took another step in the integration of Credit Suisse and closed the mergers of the vested benefits foundations (Pillar 2 - FZG) of UBS and Credit Suisse as well as of the Pillar 3a foundations of UBS and Credit Suisse. These mergers ensure that all beneficiaries of the foundations have equal access to the service offerings of UBS. The Homburger team advising on the mergers comprised Andreas Müller, Francesco Bernasconi and Thierry Burckhardt (all Corporate / M&A) and Peter Müller (Tax / Pensions). Contact Beatrice Winkler / Marketing / [email protected]

On May 23, 2025, PolyPeptide announced that it has secured additional financing of EUR 40 m under its revolving credit facility (RCF) increasing the available capital commitments to a total of EUR 151 m, with UBS as coordinator and agent, and together with Danske Bank and Zürcher Kantonalbank each as mandated lead arranger and lender. PolyPeptide is a global Contract Development & Manufacturing Organization (CDMO) specializing in the development and manufacturing of peptide- and oligonucleotide-based active pharmaceutical ingredients for the biotech and pharmaceutical industries. Homburger advised UBS and the other banks with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick and included Nathalie Scherrer (both Financing and Investment Products) and Stefan Oesterhelt (Tax).   Contact Johanna Schmid / Marketing / [email protected]

On May 27, 2025, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 19,031,811 shares in Galderma Group AG (Galderma) at a price of CHF 97.75 per share (the Placement), raising a total of ca. CHF 1,860 m in total. Galderma participated in the Placement by agreeing to repurchase 2,378,976 shares for a total consideration of ca. CHF 233 m, at the same price per share determined by the bookbuilding process. The Sellers will remain shareholders of 40.2% of the share capital of Galderma. EQT’s representation on the board of directors of Galderma remains unchanged as a result of the Placement. Such Placement will broaden Galderma's shareholder base and free float. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma. The Placement is expected to be settled on June 2, 2025. Following the Placement, no changes to the Galderma board of directors and its governance are envisioned. Homburger acted as transaction counsel to EQT. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Margrit Marti, Estelle Piccard, Héloïse de Jamblinne and Lucas Forrer (all Corporate / M&A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax). Contact Nanding Susso / Marketing / [email protected]

On May 23, 2025, Dufry One B.V. issued EUR 500 m 4.50% Senior Notes due 2032 guaranteed by Avolta AG and certain of its subsidiaries. Banca Akros SpA, BNP Paribas, ING Bank N.V., Landesbank Baden-Württemberg, Banco Santander S.A. and UBS AG London Branch acted as joint global coordinators and joint bookrunners. Bank of China Limited, London Branch, Banco Bilbao Vizcaya Argentaria, S.A., BofA Securities Europe S.A., Commerzbank Aktiengesellschaft, Crédit Agricole Corporate and Investment Bank, Crédit Industriel et Commercial S.A., Goldman Sachs Bank Europe SE, HSBC Continental Europe, Intesa Sanpaolo S.p.A., Mediobanca Banca di Credito Finanziario SpA, MUFG Securities (Europe) N.V., Raiffeisen Bank International AG and UniCredit Bank GmbH acted as joint bookrunners and Raiffeisen Schweiz Genossenschaft and DZ BANK AG Deutsche Zentral-Genossenschaftsbank, Frankfurt am Main acted as co-managers. The Homburger team comprised Andreas Müller (Capital Markets), Jürg Frick and Daniel Hulmann (both Capital Markets) as well as Dieter Grünblatt (Tax). Contact Nanding Susso / Marketing / [email protected]

On February 27, 2025, BIOTRONIK Group announced that it has entered into an agreement to divest its Vascular Intervention (VI) business division to Teleflex Incorporated. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to close before the end of the third quarter of 2025. BIOTRONIK is a Berlin-based global leader in medical technology and a pioneer in cardiovascular, endovascular, and neuromodulation solutions. Teleflex (NYSE: TFX) is a Pennsylvania-based leading global provider of medical technologies with a diverse portfolio, including solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Homburger acts as Swiss transaction counsel to BIOTRONIK. The team includes Andreas Müller, Anna Peter, Jasmin Künzle, Romain Hondius, Oliver Kneubühl and Cédric Berger (all Corporate / M&A), Richard Stäuber and Angelika Murer (both Regulatory), Luca Dal Molin and Philippe Baumann (both IP / IT), Stefan Gäumann (Real Estate), Jeremy Reichlin and Angela Casey (both Employment and Executive Compensation), as well as Reto Heuberger and Philippe Weber (both Tax). Contact Beatrice Winkler / Marketing / [email protected]

Zurich Airport Ltd. announced on May 12, 2025, its acquisition of full ownership of the Radisson Blu Building at Zurich Airport from Al Maha Real Estate AG. The acquisition was executed through an early reversion of the building right for a purchase price of approximately CHF 155 m. This strategic transaction offers new development opportunities for Zurich Airport Ltd. within the central airport perimeter. The Homburger team included Andreas Müller (Corporate / M&A), Reto Heuberger and Laetitia Fracheboud (both Tax) as well as Olivier Bühlmann (Real Estate). Contact Johanna Schmid / Marketing / [email protected]  

On June 18, 2025, EFG Bank AG successfully completed its issuance of CHF 125 m 0.9625% bonds 2025 – 2029. Raiffeisen Schweiz Genossenschaft acted as Sole Lead Manager. Homburger acted as counsel to Raiffeisen Schweiz Genossenschaft. The Homburger team was led by Benjamin Leisinger and included Olivier Baum (both Capital Markets). Contact Wanda Schweda / Marketing / [email protected]

On February 12, 2025, UBS Group AG successfully completed its issuance of EUR 1.5 bn in aggregate principal amount of 3.250 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due February 2034 and EUR 1.25 bn in aggregate principal amount of 2.875 per cent. Fixed Rate/Fixed Rate Callable Senior Notes due February 2030 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been admitted to trading and are listed on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On May 12, 2025, UBS Group AG successfully completed its issuance of EUR 1.25 bn in aggregate principal amount of Floating Rate Callable Senior Notes due 2029 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On May 9, 2025, UBS Group AG successfully completed its issuance of USD 1.75 bn in aggregate principal amount of Fixed Rate/Floating Rate Callable Senior Notes due May 2036 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On February 10, 2025, UBS Group AG successfully completed its offering of USD 1,500,000,000 in aggregate principal amount of 7.125 per cent. Tier 1 Capital Notes and USD 1,500,000,000 in aggregate principal amount of 7.000 per cent. Tier 1 Capital Notes. The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG’s Swiss going concern requirements. Upon occurrence of a "Trigger Event" or a "Viability Event", the Notes will be converted into ordinary shares of UBS Group AG in accordance with their terms. The Notes are governed by Swiss law and have been admitted to trading and are listed on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets), Claude Lambert (Corporate / M&A), as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On June 27, 2025, Raiffeisen Schweiz Genossenschaft successfully completed its issuance of CHF 250 m 0.785 per cent. fixed rate green bonds due 2030 under its issuance program for money market instruments, bonds and green bonds. This issuance marks the first issuance of a green bond by Raiffeisen Schweiz Genossenschaft. Raiffeisen Schweiz Genossenschaft acted as Sole Lead Manager and BNP Paribas, Commerzbank, Deutsche Bank and UBS Investment Bank acted as Managers. Homburger acted as counsel to Raiffeisen Schweiz Genossenschaft. The Homburger team was led by Benjamin Leisinger and included Olivier Baum (both Capital Markets).   Contact Wanda Schweda / Marketing / [email protected]

On 30 May 2025 and 4 June 2025, respectively, SIX issued EUR 500 m guaranteed bonds due 2030 and CHF 250 m digital bonds due 2032 (the Bonds). The Bonds have been admitted to provisional trading and will be listed on the SIX Swiss Exchange. Clearing and settlement for the EUR 500 m guaranteed bonds, which have been issued by SIX Finance (Luxembourg) S.A. and are guaranteed by SIX Group AG, occurs via Euroclear and Clearstream Banking S.A. and for the CHF 250 m digital bonds, which have been directly issued by SIX Group AG, in digital form via SIX Digital Exchange AG (with further clearing through SIX SIS AG and any other eligible clearing system). For the EUR 500 m guaranteed bonds, BNP PARIBAS, BofA Securities Europe SA, Deutsche Bank Aktiengesellschaft and UBS AG, London Branch, acted as Active Bookrunners, and Banco Bilbao Vizcaya Argentaria, S.A., CaixaBank, S.A., Citigroup Global Markets Europe Limited and HSBC Continental Europe as Passive Bookrunners. For the CHF 250 m digital bonds, UBS AG, Raiffeisen Schweiz Genossenschaft, and Zürcher Kantonalbank acted as the Joint Lead Managers. The Homburger team was led by Benjamin Leisinger and Eduard De Zordi (both Capital Markets). Tax aspects were covered by Stefan Oesterhelt (Tax).   Contact Johanna Schmid / Marketing / [email protected]

On February 28, 2025, the Court of Arbitration of SIX Group AG issued a precedent-setting award, finding that Clariant AG had published the ad hoc announcement concerning the financial reporting matters under investigation in winter 2021/22 in a timely manner. As a result, the tribunal annulled the fine previously imposed by the Sanctions Commission of SIX Group AG in this respect. For the first time, the tribunal provided guidance on the ad hoc disclosure threshold in the context of internal investigations and upheld Clariant’s position that the Listing Rules of SIX Exchange Regulation AG protect an issuer’s duly exercised discretion in deciding whether to issue an ad hoc announcement. In relation to a negligent violation of the ad hoc disclosure regulations concerning the publication of the 2021 Integrated Report, the tribunal imposed a reduced fine of CHF 100,000 for not labeling the announcement as an ad hoc announcement («flagging»). This seminal decision largely overturns an earlier decision by the Sanctions Commission, which had found that Clariant AG grossly negligently violated the ad hoc disclosure regulations by publishing the February 14, 2022 announcement concerning the ongoing investigation too late, and by not labeling the 2021 Integrated Report via an ad hoc announcement. The Sanctions Commission had imposed a total fine of CHF 500,000 on Clariant AG. Clariant AG challenged the Sanctions Commission's decision by initiating arbitration proceedings before the SIX Court of Arbitration. The arbitral award is final and legally binding. It marks the first time that an issuer prevails in arbitration proceedings against SIX Exchange Regulation AG in an ad hoc disclosure matter. The Homburger team comprised Frank Gerhard (Corporate / M&A, Capital Markets), Mariella Orelli (Litigation, Arbitration), Micha Fankhauser (Corporate / M&A, Capital Markets) and Richard G. Allemann (Litigation, Arbitration).   Contact Johanna Schmid / Marketing / [email protected]

On June 12, 2024, ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced the private placement of 13.0 m common shares and pre-funded warrants to purchase 15.7 m common shares, raising aggregate gross proceeds of USD 100 m. The Homburger team was led by Daniel Häusermann (Corporate / M&A, Capital Markets) and included Bianca Nedwed and Estelle Piccard (both Corporate / M&A, Capital Markets) as well as Stefan Oesterhelt and Philippe Weber (both Tax). Contact Wanda Schweda / Marketing / [email protected]

On August 14, 2024, BayWa r.e. AG and certain of its group companies entered into a EUR 932,000,000 bridge facilities agreement (the Bridge Facilities Agreement) with a syndicate of lenders coordinated by Commerzbank AG, Deutsche Bank AG, DZ BANK AG and others. The Bridge Facilities Agreement served as the foundation for the group’s interim refinancing in the context of a broader liquidity and restructuring process. Homburger acted as local counsel to BayWa r.e. AG and, in particular, to its Swiss subsidiary, Solarmarkt GmbH, advising on Swiss-law aspects of the transaction. Following the initial financing, Homburger continued to advise BayWa r.e. AG on a series of successive agreements that governed and implemented the restructuring framework. These included the standstill agreement dated October 2, 2024, which amended and extended the original arrangement, as well as the Heads of Terms Agreement dated December 20, 2024. Homburger also advised in connection with the first amendment to the Bridge Facilities Agreement dated October 2, 2024, the second amendment and restatement agreement dated January 29, 2025, and the third amendment agreement dated March 27, 2025. BayWa r.e. AG is one of the leading global developers, service providers, distributors and solution suppliers in the field of renewable energy. The Homburger team was led by Daniel Haeberli and included Sarah Fasel, Simone Gloor and Caroline Grand (all Financing).   Contact Wanda Schweda / Marketing / [email protected]

On May 27, 2025, BeOne Medicines Ltd., a global oncology company, officially completed its redomiciliation from the Cayman Islands to Basel, Switzerland, following shareholder approval on April 28, 2025. The redomiciliation to Switzerland strengthens BeOne’s presence and deepens its roots in a global biopharmaceutical hub, further enabling its growth strategy of bringing innovative medicines to patients around the world. BeOne Medicines Ltd.'s American Depositary Shares are listed on the Nasdaq Global Select Market, each representing 13 ordinary shares of BeOne Medicines Ltd., each having a par value of USD 0.0001 per share (the “Ordinary Shares”), the Ordinary Shares are listed on The Stock Exchange of Hong Kong Limited, and the Ordinary Shares traded in Renminbi are listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The Homburger team was led by David Oser (Corporate / M&A, Capital Markets) and included Bianca Nedwed and Kaiyan Yeo (both Corporate / M&A, Capital Markets), Stefan Bindschedler and Benjamin Leisinger (Banking and Finance) as well as Stefan Oesterhelt and Juliette Buob (both Tax). Contact Johanna Schmid / Marketing / [email protected]

On June 19, 2025, Julius Baer Group Ltd. issued EUR 500 m notes (the Notes). The issuance occurred indirectly through the ELM issuance vehicle, a repackaging issuance entity incorporated in the Netherlands. The Notes will be listed on Euronext Dublin. For the Notes, UBS AG, London Branch, BNP PARIBAS, Citigroup Global Markets Europe AG and J.P. Morgan SE acted as Joint Lead Managers. The Homburger team was led by Benjamin Leisinger and Eduard De Zordi (both Capital Markets). Tax aspects were covered by Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On June 25, 2025, Idorsia Ltd published its public repurchase offer (the Exchange Offer) to exchange its CHF 200 m senior unsecured convertible bonds due 2025 and its CHF 600 m senior unsecured convertible bonds due 2028 (the Bonds). The Bonds will be exchanged for an offer consideration consisting of (i) a series of newly issued „Pay-If-You-Can“ notes with waterfall rankings issued by a Luxembourg special purpose subsidiary, which will be listed on the International Stock Exchange, (ii) shares of Idorsia Ltd and (iii) warrants of Idorsia Ltd. The Swiss Takeover Board has made determinations and granted exemptions regarding the Exchange Offer in its ruling dated June 5, 2025. The Exchange Offer is part of the holistic restructuring and refinancing of the Idorsia group announced by Idorsia Ltd on February 26, 2025. The Homburger team was led by Frank Gerhard (Corporate / M&A, Capital Markets) and included Marco Rostetter (Corporate / M&A, Restructuring / Insolvency), Micha Fankhauser, Estelle Piccard and Anina Preusker (all Corporate / M&A) as well as Eduard De Zordi and Daniel Hulmann (both Capital Markets). Contact Johanna Schmid / Marketing / [email protected]

On June 30, 2025, Yoda PLC, a Cyprus-based investment corporation listed on the Cyprus stock exchange (CSE: YODA), announced the completion of its investment into ULTIMA CAPITAL SA, a Swiss luxury real estate owner, developer and operator listed on BX Swiss (BX: ULTIMA). As part of the transaction, Yoda has transferred to Ultima, by way of a contribution in kind, 100% of the issued share capital of its wholly-owned subsidiary Bakaso Holdings Limited at a contribution value of CHF 120.0 m in exchange for 2,000,000 newly-issued shares in Ultima. Bakaso indirectly owns various commercial properties valued at approximately EUR 133.7 m primarily in the food and beverage and retail sector located in the areas of Psarrou and Ano Mera, Mykonos, Greece, including the Nammos beach-bar restaurant and the seven-building Nammos Village retail area. As a result of the transaction, Yoda increased its shareholding in Ultima from previously approximately 53.8% to approximately 64.0% post-completion. Homburger advised Yoda on all aspects of the transaction. The Homburger team was led by Lorenzo Togni and included Jonas Stähli and Viviane Egli (all Corporate / M&A) as well as Claudia Suter and Philippe Weber (both Tax). Stefan Blunschi and Micha Frankhauser (both Corporate / M&A) also contributed to the transaction. Contact Nanding Susso / Marketing / [email protected]

On March 6, 2026, Roche Holding AG, Roche Holdings, Inc. and Roche Finanz AG entered into a Swiss law governed USD 7.5 bn revolving credit facility agreement arranged by and syndicated among twelve international banks, coordinated by Deutsche Bank. The Homburger team was led by Jürg Frick and Stefan Bindschedler and included Samuel Fäh and Yulia Shaburnykova (all Financing, Investment Products) as well as Stefan Oesterhelt (Tax).   Contact Wanda Schweda / Marketing / [email protected]

On March 7, 2025, Thermo Fisher Scientific Inc. successfully completed its issuance of its CHF bonds in an aggregate amount of CHF 1.425 bn, being the largest Swiss franc bond issuance from a US corporate issuer ever. The issuance consisted of five tranches. The bonds are governed by Swiss law and have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the bonds, on the SIX Swiss Exchange. UBS Investment Bank, BNP Paribas (Suisse) SA, and Deutsche Bank AG London Branch, acting through Deutsche Bank AG Zurich Branch, acted as lead managers. Homburger advised Thermo Fisher Scientific Inc. with respect to the legal, transactional and tax aspects of Swiss law. The Homburger team was co-led by Benjamin Leisinger and Lee Saladino and included Daniel Hulmann (all Capital Markets) as well as Stefan Oesterhelt (Tax).

The Berlin-based HR Group has acquired H-Hotels, one of the largest privately managed German hotel companies. The transaction took effect on February 25, 2025, and comprises more than 60 hotels in Germany, Austria, Switzerland, France and Hungary. HR Group is a Berlin-based company that has been acquiring, developing, and operating hotels and resorts for more than 15 years. Homburger acted as Swiss transaction counsel to HR Group. The Homburger team comprised Andreas Müller, Anna Peter, Thierry Burckhardt, Miriam Oelgarth and Carolina Rodriguez (all Corporate / M&A), Stefan Bindschedler and Michelle Wolf (both Financing and Investment Products), Stefan Gäumann and Olivier Bühlmann (both Real Estate) as well as Stefan Oesterhelt and Philippe Gobet (both Tax). Contact Beatrice Winkler / Marketing / [email protected]

On July 8, 2025, Zürcher Kantonalbank successfully completed its issuance of EUR 500 m 2.762 per cent. Fixed Rate Bonds due July 8, 2030 (the Bonds). The senior unsecured Bonds have been issued under Zürcher Kantonalbank’s Swiss base prospectus consisting of the applicable summary and securities note for the issue of bonds and STNs of Zürcher Kantonalbank dated June 20, 2025 and the registration form for debt securities dated June 20, 2025 approved by SIX Exchange Regulation AG and final terms issued thereunder. BNP PARIBAS, Deutsche Bank Aktiengesellschaft, UBS AG London Branch, and Zürcher Kantonalbank acted as the Joint Lead Managers. Homburger acted as counsel to Zürcher Kantonalbank as issuer. The Homburger team was led by Benjamin Leisinger and included Daniel Hulmann and Yulia Shaburnykova (all Capital Markets). Tax aspects were covered by Dieter Grünblatt. Contact Wanda Schweda / Marketing / [email protected]

On July 7, 2025, wefox Holding AG announced that it has secured funding of EUR 151 m, consisting of a EUR 76 m capital raise primarily from existing investors and a refinancing of an existing credit facility with EUR 75 m from Searchlight Capital Partners’ credit fund, Searchlight Opportunities Fund II. The funding follows a successfully completed business restructuring program in various jurisdictions and changes to the governance framework of wefox Holding AG. The Homburger team comprised Andreas Müller, Marco Rostetter, Lucas Forrer, Oliver Kneubühl, Miriam Oelgarth, Norina Tröhler and Carolina Rodriguez (all Corporate / M&A), Jürg Frick, Stefan Bindschedler and Nathalie Scherrer (all Financing and Investment Products), Stefan Oesterhelt, Juliette Buob, Laetitia Fracheboud and Philippe Gobet (all Tax), Stefan Kramer (Restructuring) and Karin Mattle, Angela Casey and Luca Ellenberger (all Employment and Executive Compensation). Contact Wanda Schweda / Marketing / [email protected]

March 23 2026 AECOM acquired Consigli, a leading Norwegian AI company transforming engineering and early-stage project design. The Homburger team advising AECOM on this transaction comprised Andreas Müller, Luca Ellenberger and Thierry Burckhardt (all Corporate / M&A), Laetitia Fracheboud (Tax), Luca Dal Molin and Joel Fink (both IP / IT) as well as Allegra Arnold (Competition).     Contact Wanda Schweda / Marketing / [email protected]

Homburger acted as counsel to Swarovski International Holding AG and its Subsidiaries in connection with an up to EUR 550 m financing, with UBS Switzerland AG as Coordinating and Bookrunning Mandated Lead Arranger, Facility Agent and Security Agent and BNP PARIBAS, Paris, Lancy/Geneva Branch and Zürcher Kantonalbank as Coordinating and Bookrunning Mandated Lead Arrangers as well as an international and Swiss syndicate of banks as Lenders. Homburger advised Swarovski with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick (Financing and Investment Products) and included Nathalie Scherrer and Sarah Fasel (both Financing) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On June 30, 2025, Cibes Lift Group successfully acquired Meier + Co. AG, the leading supplier of vertical platform lifts and stair lifts in Switzerland. Through the acquisition, Cibes expanded its direct sales presence to Switzerland, strengthening its position on the European market. A distributor for Cibes Lift Group since 2007, Meier + Co. AG offers lift solutions to public, commercial and residential customers, providing a full range of customer services, including sales, installation, maintenance and 24/7 support. Founded in 1952, Meier + Co. AG is based in Niedergösgen and has approximately 30 employees. The Homburger team was led by Dieter Gericke and included Daniel Häusermann, Kaiyan Yeo, and Adrian Schwarz (all Corporate / M&A), Reto Heuberger and Philippe Weber (both Tax), Gregor Bühler and Hélène Bruderer (both Employment), as well as Stefan Gäumann and Dominique Burà (both Real Estate). Contact Johanna Schmid / Marketing / [email protected]

On June 2, 2025, the German vehicle inspection company DEKRA SE announced the acquisition of an additional stake in Spearhead AG, a Swiss company specializing in data analytics for automotive claims and vehicle lifecycle management. As a result of the transaction, DEKRA SE became the majority shareholder of Spearhead AG. Homburger acted as legal counsel to DEKRA SE. Gregor Bühler (IP / IT) led the Homburger team, which included Romain Fakhoury-Hondius (Corporate / M&A) and Philippe Baumann (IP / IT). Contact Nanding Susso / Marketing / [email protected]

Homburger acted as Swiss counsel to Altri, SGPS, S.A. (Altri), a leading Portuguese producer of sustainable cellulosic pulp, in connection with its strategic acquisition of a majority stake in AeoniQ Holding AG (AeoniQ), a Swiss-based cleantech spin-off of HeiQ Materials AG. The transaction will support the industrial scaling of AeoniQ, a climate-positive, biodegradable cellulosic filament yarn engineered to replace polyester and nylon. The Homburger team was led by Daniel Hasler and included Estelle Piccard, Nicola Togni, Florian Bruggisser and Yannick Reber (all Corporate / M&A) as well as Joel Fink (IP / IT). Contact Wanda Schweda / Marketing / [email protected]

Homburger acted as counsel to UBS Switzerland AG as mandated lead arranger, agent, security agent and original lender in connection with the financing of the acquisition of a majority stake in Horizon Home Care Group AG, a Swiss-based international provider of non-medical home care services operating under the brand Dovida, by Ardian. Dovida provides person-centered non-medical home care which is carefully designed to support, empower and uplift individuals, and enhance their quality of life. Dovida’s global footprint spans six countries (Australia, Ireland, France, Netherlands, New Zealand, and Switzerland) delivering nine million hours of care each year. With a global presence and a local touch, Dovida delivers care that’s personal, empowering, and impactful. Homburger advised UBS Switzerland AG with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Jürg Frick and included Stefan Bindschedler, Nathalie Scherrer and Sarah Fasel (all Financing) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On January 15, 2026, HIAG Immobilien Holding AG, a leading player in the real estate industry in Switzerland that covers the entire property value chain of portfolio/asset management, site development and transaction management, placed CHF 100 m in aggregate principal amount of 1.340 percent Green Bonds due 2033 (the Green Bonds). Raiffeisen Schweiz Genossenschaft and Basler Kantonalbank acted as Joint Lead Managers. The Green Bonds will be listed on the SIX Swiss Exchange. Homburger advised Raiffeisen Schweiz Genossenschaft in the transaction. The Homburger team was led by Benjamin Leisinger (Capital Markets) and included Yulia Shaburnykova (Capital Markets). Contact Wanda Schweda / Marketing / [email protected]  

On July 28, 2025, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 17 million shares in Galderma Group AG (Galderma) at a price of CHF 123 per share (the Placement), raising a total of ca. CHF 2,091 million in total. The Sellers will remain shareholders of 33.0% of the share capital of Galderma. EQT’s representation on the board of directors of Galderma remains unchanged as a result of the Placement. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma. The Placement is expected to be settled on July 31, 2025. BNP PARIBAS, Citigroup, Goldman Sachs International, Jefferies GmbH, Morgan Stanley & Co. International plc and UBS are acting as Joint Global Coordinators and Joint Bookrunners in the Placement. Homburger acted as transaction counsel to EQT. The Homburger team was led by Frank Gerhard and Margrit Marti (Corporate / M&A, Capital Markets) and included Estelle Piccard, Héloïse de Jamblinne and Lucas Forrer (all Corporate / M&A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On August 5, 2025, UBS Group AG successfully completed its offering of USD 1,250,000,000 in aggregate principal amount of 7.000 per cent. Tier 1 Capital Notes and USD 750,000,000 in aggregate principal amount of 6.600 per cent. Tier 1 Capital Notes. The Notes are «high trigger» regulatory capital instruments that are eligible to fulfill UBS Group AG’s Swiss going concern requirements. Upon occurrence of a «Trigger Event» or a «Viability Event», the Notes will be converted into ordinary shares of UBS Group AG in accordance with their terms. The Notes are governed by Swiss law and have been admitted to trading and are listed on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Olivier Baum (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

On August 11, 2025, UBS Group AG successfully completed its issuance of EUR 1.25 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due 2036 and EUR 750 m in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due 2031 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Johanna Schmid / Marketing / [email protected]

Homburger AG acted as Swiss counsel to RV AIP S.C.S. SICAV-SIF acting for partial fund RV TF ACQUISITION FINANCING in its capacity as lender in connection with EUR 31 m credit financing of European AV Group. The Homburger team was led by Daniel Haeberli (Financing) and included Simone Gloor and Céline Rüegg (both Financing) as well as Stefan Oesterhelt (Tax). Contact Gloria Pünchera / Marketing / [email protected]

September 8, 2025 On September 4, 2025, Zürcher Kantonalbank successfully completed a further offering of Bail-in Bonds in the amount of EUR 500 m. ZKB’s Bail-in Bonds, including the newly placed EUR 500 m 3.153% 6NC5 Bail-in Bonds, have been designed and issued on the basis of a legal framework allowing Cantonal Banks to issue Total-Loss-Absorbing-Capacity (Gone-Concern Capital) Bonds. If FINMA orders the partial or complete reduction of the bondholders’ claims under the Bail-in Bonds, the bondholders are entitled to receive Recovery Certificates. Such Recovery Certificates include claims, subject to multiple conditions precedent, for subsequent future compensation payments for the full or partial reduction of the bondholders’ claims under the Bail-in Bonds. BNP PARIBAS, Deutsche Bank, UBS Investment Bank and Zürcher Kantonalbank acted as Joint Lead Managers. The team was led by Benjamin Leisinger and included Daniel Hulmann (both Capital Markets and Financial Market Regulation). Tax aspects were covered by Dieter Grünblatt (Tax).   Contact Wanda Schweda / Marketing / [email protected]

On September 8, 2025, The SPAR Group Ltd entered into an agreement to sell its entire shareholding in SPAR Holding AG including its Swiss business operations (SPAR Switzerland) to Tannenwald Holding AG. The sale has been completed with immediate effect. SPAR Switzerland operates approximately 358 stores and owns 11 cash & carry outlets and one distribution centre in Switzerland, all under several formats including SPAR, SPAR Express, EUROSPAR, Maxi and TopCC. The transaction reflects an equity value of CHF 46.5 m and includes potential earn-out payments of up to CHF 30 m due at the end of FY27 based on certain EBITDA milestones. The Homburger team was led by Frank Gerhard and comprised Patrick Schmidt, Carlo Sulser, Florian Bruggisser, Jannis Zafeirakos and Leon Indov (all Corporate / M&A), Richard Stäuber, Andreas Burger and Kristina Martinovic (all Competition), Stefan Oesterhelt, Reto Heuberger, Juliette Buob and Philippe Weber (all Tax), Stefan Bindschedler (Financing and Investment Products) as well as Luca Dal Molin and Noëmie Beck-Schär (both IP / IT) and Jeremy Reichlin (Employment). Contact Wanda Schweda / Marketing / [email protected]

On August 13, 2025, UBS Switzerland AG successfully completed its issuance of CHF 235 m 0.560 per cent. Fixed Rate Covered Bonds due August 13, 2030, and CHF 275 m 0.935 per cent. Fixed Rate Covered Bonds due August 13, 2035, under its Covered Bond Programme. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG’s domestic mortgage pool. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Daniel Hulmann, Sofiya Shavlak and Céline Rüegg (all Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On September 9, 2025, UBS Switzerland AG successfully completed its issuance of EUR 1 bn 2.783 per cent. Fixed Rate Covered Bonds due September 9, 2030, under its Covered Bond Programme. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG’s domestic mortgage pool. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Daniel Hulmann, Yulia Shaburnykova and Céline Rüegg (all Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On September 9, 2025, Givaudan Finance Europe B.V. successfully completed its issuance of EUR 500 m 2.875 per cent. Guaranteed Bonds due 2029 guaranteed by Givaudan SA. The Bonds are governed by English law and listed on Euronext Dublin. The Homburger team was led by Daniel Haeberli and included Daniel Hulmann (both Capital Markets) and Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On July 17, 2025, Madrigal Pharmaceuticals, Inc., a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need, secured a USD 500 m senior secured credit facility from Blue Owl Capital to advance its pharmaceutical pipeline. On September 4, 2025, Madrigal’s Swiss subsidiary, Madrigal Pharmaceuticals GmbH, acceded as guarantor and security provider to this financing. Homburger advised Madrigal, in particular its Swiss subsidiary Madrigal Pharmaceuticals GmbH, with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Daniel Haeberli and included Fabrice Eckert, Luca Gmür and Yulia Shaburnykova (all Financing) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On September 23, 2025, UBS Group AG successfully completed its issuance of (i) USD 1.25 bn Fixed Rate/Floating Rate Callable Senior Notes due December 2029, (ii) USD 700 m Floating Rate Callable Senior Notes due December 2029, (iii) USD 1 bn Fixed Rate/Floating Rate Callable Senior Notes due September 2031, (iv) USD 300 m Floating Rate Callable Senior Notes due September 2031, and (v) USD 1.75 bn Fixed Rate/Floating Rate Callable Senior Notes due March 2037 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. Homburger advised UBS Group AG with respect to all regulatory and transactional aspects of Swiss law. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Lee Saladino and Olivier Baum (all Capital Markets), as well as Stefan Oesterhelt (Tax).   Contact Nanding Susso / Marketing / [email protected]

On September 23, 2025, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had secured an USD 13 m royalty monetization financing with R-Bridge, an affiliate of CBC Group, Asia’s largest healthcare-focused investment firm. Santhera is monetizing 25% of net royalties on its product AGAMREE®. In addition, Santhera has agreed with Highbridge Capital Management, LLC on an additional CHF 10 m of funding and the exchange of the existing CHF 7 m private convertible bond for a new convertible bond. Homburger advises Santhera on the transaction. The Homburger team is led by Daniel Häusermann (Corporate / M&A, Capital Markets) and includes Stefan Oesterhelt (Tax), Eduard De Zordi and Daniel Hulmann (both Financing, Investment Products, Capital Markets) as well as Daniel Bötticher (Corporate / M&A). Ropes & Gray acts as U.S. counsel to Santhera.   Contact Wanda Schweda / Marketing / [email protected]

On September 17, 2025, Luzerner Kantonalbank AG issued CHF 200 m 1.400% Tier 2 Bonds. Luzerner Kantonalbank AG and UBS AG acted as joint-lead managers. The bonds will be listed on the SIX Swiss Exchange. Homburger acted as counsel to Luzerner Kantonalbank AG. The Homburger team consisted of Benjamin Leisinger and Eduard De Zordi (both Capital Markets).

On August 29, 2025, September 17, 2025 and September 30, 2025, respectively, 21Shares AG, a leading global issuer of crypto exchange traded products (ETPs), successfully issued and listed three new series of crypto-linked ETPs on the SIX Swiss Exchange. The first series, 21Shares Hyperliquid ETP (HYPE), has Hyperliquid (HYPE) as underlying, the native token of Hyperliquid, a high-performance Layer 1 blockchain featuring a fully on-chain order book perpetuals exchange. The second series, 21Shares Raydium ETP (ARAY) tracks the performance of Raydium (RAY), the native utility token of an automated market maker and liquidity provider Raydium built on the Solana blockchain for the Serum decentralized exchange, that is used for staking to earn protocol fees, staking to receive IDO allocations and governance votes on protocol decisions. The third series, 21Shares Jupiter ETP (AJUP) is linked to Jupiter (JUP), the native cryptocurrency of the decentralized exchange aggregator and decentralized finance platform on the Solana blockchain Jupiter. All of these ETPs are traded in the trading currencies USD and EUR. Further, on August 12, 2025, and September 16, 2025 21Shares AG successfully cross-listed three existing series of crypto-linked ETPs on the SIX Swiss Exchange. The first series, the 21Shares XDC Network ETP (XDCN), tracks the performance of XDC Network (XDC), the cryptocurrency that serves as the native utility token powering the XDC Network, a blockchain developed to support trade finance and the tokenization of real-world assets. The second series, the 21Shares Sui Staking ETP (ASUI), has Sui (SUI) as underlying, a native token of Sui network, a Layer 1 blockchain optimizing for low-latency blockchain transfers. The last series, the 21Shares Chainlink ETP (LINK), is linked to the performance of Chainlink (LINK), the cryptocurrency of Chainlink (LINK), the decentralized oracle network that connects smart contracts with off-chain data and services. These ETPs are traded on the SIX Swiss Exchange in the trading currency USD. Homburger acted as Swiss legal counsel to 21Shares AG. The Homburger team was led by Benjamin Leisinger and included Sofiya Shavlak (both Capital Markets).

On September 29, 2025, Landis+Gyr Group AG, a leading global provider of integrated energy management solutions, announced that it has entered into a share purchase agreement to divest its operations in the Europe, Middle East and Africa (EMEA) region to AURELIUS, a global private equity investor, for an enterprise value of USD 215 m. The transaction encompasses the full metering portfolio for residential electricity, ICG electricity, gas, thermal, water, as well as the related integrated solutions for software and services. The divestment includes five production sites across the region and involves a workforce of approximately 2,700 employees. The transaction is subject to customary regulatory approvals and other closing conditions, and is expected to close in Q2 2026. The Homburger team is led by Daniel Hasler (Corporate / M&A) and includes Anna Peter, Patrick Schmidt, Nicola Togni, Carlo Sulser, Filip Lapadatovic and Fabio Gasser (all Corporate / M&A), Gregor Bühler, Philippe Baumann, Joel Fink and Kristina Martinovic (all IP / IT), Reto Heuberger, Philippe Weber and Juliette Buob (all Tax), Peter Müller (Pension), Richard Stäuber (Competition), as well as Jürg Frick and Stefan Bindschedler (both Financing). Contact Johanna Schmid / Marketing / [email protected]

On September 29, 2025, UBS Group AG successfully completed its offering of AUD 1.25 bn in aggregate principal amount of 6.375 per cent. Tier 1 Capital Notes. The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG’s Swiss going concern requirements. Upon occurrence of a "Trigger Event" or a "Viability Event", the Notes will be converted into ordinary shares of UBS Group AG in accordance with their terms. The Notes are governed by Swiss law and have been admitted to trading and are listed on the SIX Swiss Exchange. The Homburger team was led by Benedikt Maurenbrecher and Stefan Kramer (both Capital Markets) and included Lee Saladino and Olivier Baum (both Capital Markets) as well as Stefan Oesterhelt (Tax).

On October 10, 2025, Danaher successfully completed its issuance of five tranches of CHF bonds in an aggregate principal amount of CHF 1.25 bn, consisting of (i) CHF 250 m in aggregate principal amount of 0.4773% Guaranteed Bonds due April 9, 2027, (ii) CHF 325 m in aggregate principal amount of 0.8875% Guaranteed Bonds due October 10, 2029, (iii) CHF 325 m in aggregate principal amount of 1.2650% Guaranteed Bonds due October 10, 2033, (iv) CHF 225 m in aggregate principal amount of 1.6249% Guaranteed Bonds due October 9, 2037, and (v) CHF 125 m in aggregate principal amount of 1.9400% Guaranteed Bonds due October 10, 2045. The bonds were issued by the Luxembourg finance subsidiary DH Switzerland Finance S.à r.l. and guaranteed by Danaher Corporation, the parent company of the Danaher group. The bonds are governed by Swiss law and have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the bonds, on the SIX Swiss Exchange. BNP PARIBAS, Paris, Lancy/Geneva Branch, Commerzbank Aktiengesellschaft and Deutsche Bank Aktiengesellschaft, acting through Deutsche Bank AG Zurich Branch, acted as joint lead managers. Danaher was advised by Homburger as Swiss counsel, WilmerHale as U.S. counsel, and DLA Piper as Luxembourg counsel. The joint lead managers were advised by Schellenberg Wittmer as Swiss counsel. The Homburger team was co-led by Benjamin Leisinger and Lee Saladino (both Capital Markets) and included Olivier Baum and Yulia Shaburnykova (both Capital Markets), as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On October 10, 2025, SIX-listed Idorsia Ltd announced the launch of an accelerated bookbuilding offering, which led to the successful placement of 16.4 m shares at an offer price of CHF 4.00 per offered share, raising aggregate gross proceeds of approximately CHF 65.6 m. The offering was conducted by way of (i) a placement to professional investors in Switzerland or in any other circumstances relying on an exemption from the obligation to publish a prospectus under the Swiss Financial Services Act, (ii) private placements in certain jurisdictions outside of Switzerland and the United States, and (iii) private placements within the United States to qualified institutional buyers in reliance on Rule 144A under the U.S. Securities Act. Idorsia Ltd intends to use the net proceeds from the offering to accelerate QUVIVIQ’s commercial trajectory, to advance its pipeline, to strengthen its balance sheet, and for general corporate purposes. J.P. Morgan and UBS are acting as Joint Bookrunners and Global Coordinators, and H.C. Wainwright & Co. is acting as Lead Manager in connection with the offering. The Homburger team was led by Frank Gerhard (Corporate / M&A) and included Lorenzo Togni (Capital Markets), Estelle Piccard, Lucas Forrer, Anina Preusker and Jannis Zafeirakos (all Corporate / M&A) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On October 13, 2025, Allwyn International AG and OPAP S.A. announced that their respective boards of directors have approved the business combination of Allwyn and OPAP through an all-share transaction that values the resulting entity at an equity value of EUR 16 bn. The Combined Company will be renamed Allwyn. It will remain listed on the Main Market of the Athens Stock Exchange and intends to pursue an additional listing on another leading international exchange such as London or in New York following closing. The transaction will bring together two leading gaming operators, creating the second largest listed gaming entertainment company globally, with multiple diverse, fast-growing and market-leading positions across Europe, the United States and other international markets. The Homburger team includes Anna Peter, Flavio Romerio and Bianca Nedwed (all Corporate / M&A). Contact Wanda Schweda / Marketing / [email protected]

On October 8, 2025, ABB Ltd announced it has signed an agreement to divest its robotics division to SoftBank Group Corp. for an enterprise value of USD 5.375 bn. ABB’s robotics business is one of the world’s leading robotics suppliers with a global customer base and approximately 7,000 employees. The sale is subject to a carve-out through a multi-jurisdictional reorganization which will conclude prior to closing. Completion is also subject to the receipt of customary regulatory clearances. Homburger acts as Swiss counsel to ABB. The Homburger team includes Claude Lambert, Andreas Müller, Anna Peter, Estelle Piccard, Claudine Schär, Simone Schmid and Luca Ellenberger (all Corporate / M&A), Reto Heuberger, Peter Müller and Juliette Buob (all Tax) as well as Andri Hess and Noëmie Beck-Schär (both IP/IT). Contact Wanda Schweda / Marketing / [email protected]  

On October 13, 2025, ADC Therapeutics SA (NYSE: ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced a USD 60 m private investment in public equity (“PIPE”) financing. In the PIPE, 11.3 m common shares and pre-funded warrants to purchase 3.8 m common shares were sold. The PIPE is led by TCGX and includes participation from Redmile Group and other existing investors. The Homburger team was led by Daniel Häusermann (Corporate / M&A, Capital Markets) and included Bianca Nedwed (Corporate / M&A, Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]  

On October 22, 2025, Marex Group plc, a diversified global financial services platform, announced that it had agreed to acquire Valcourt SA. Valcourt is a fixed-income market maker based in Geneva, Switzerland, specializing in fixed-income instruments such as high-yield, subordinated, emerging markets, private, illiquid, and sustainable debt. The acquisition will add 700 clients, ranging from banks, independent wealth managers and asset managers. The acquisition is expected to enhance Marex’s fixed-income business and bring a substantial distribution offering that serves the Swiss institutional community, in particular private banks, and wealth and asset management companies, consistent with Marex’s strategy to add new clients and new capabilities to its platform to diversify earnings. The deal is subject to regulatory approval and is expected to close in the first half of 2026. The Homburger team comprises Andreas Müller, Thierry Burckhardt (both Corporate / M&A), Benjamin Leisinger, Carla Bertossa (both Regulatory), and Philippe Gobet (Tax). Contact Wanda Schweda / Marketing / [email protected]  

On October 22, 2025, Barnes Group Inc. announced that it has successfully separated into two companies, Barnes Aerospace and The Industrial Solutions Group, each with its own leadership team and capital structure. Barnes Aerospace is a premier provider for the full life-cycle supply and repair of complex aeroengine components from fan to exhaust. The Industrial Solutions Group is a leading manufacturer of highly engineered, high-quality precision products, systems, and solutions for critical applications. Homburger advised Barnes Group Inc. on the Swiss law aspects of the transaction. The Homburger team was led by Claude Lambert (Corporate / M&A) and included Daniel Bötticher, Eric Huber, Alessandro Samà and Carolina Rodríguez (all Corporate / M&A) as well as Reto Heuberger, Peter Müller and Philipp Stiegeler (all Tax).

Homburger acted as counsel to Metall Zug AG in respect of a new CHF 220 m syndicated, mortgage-backed revolving credit facility arranged by Zürcher Kantonalbank for the financing of investments in real estate developments on a former industrial site in Northern Zug, the so-called Tech Cluster Zug. Metall Zug AG is a holding company with a diversified portfolio of three directly controlled business units and strategic investments in Swiss small-cap industrial companies. Metall Zug is headquartered in Zug and employs around 1,000 people worldwide. Homburger advised Metall Zug AG with regard to all Swiss legal aspects of the financing transaction. The Homburger team was led by Stefan Bindschedler (Financing) and further included Claude Lambert (Corporate / M&A), Sarah Fasel (Financing) and Daniel Junginger (Financing, Real Estate) as well as Stefan Oesterhelt (Tax).   Contact Wanda Schweda / Marketing / [email protected]  

On November 21, 2025, UBS AG, acting through its London branch, successfully completed its issuance of EUR 750 m in aggregate principal amount of Floating Rate Notes due 2027 under its Euro Note Programme. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax).   Contact Wanda Schweda / Marketing / [email protected]  

On October 6, 2025, Sonova Holding AG issued CHF 150 m bonds. Zürcher Kantonalbank and Deutsche Bank AG Zurich Branch acted as managers. The bonds are listed on the SIX Swiss Exchange. Homburger acted as counsel to Sonova Holding AG. The Homburger team consisted of Jürg Frick and Eduard De Zordi (both Capital Markets). Contact Wanda Schweda / Marketing / [email protected]

On October 8, 2025, Siegfried Holding AG successfully priced the offering of its CHF 300 m 1.3% bonds. Zürcher Kantonalbank and Commerzbank Aktiengesellschaft acted as managers. The bonds will be listed on the SIX Swiss Exchange. Homburger acted as counsel to Siegfried Holding AG. The Homburger team consisted of Benjamin Leisinger and Eduard De Zordi (both Capital Markets).   Contact Wanda Schweda / Marketing / [email protected]

On November 6, 2025, UBS Group AG successfully completed its issuance of USD 2 bn Fixed Rate/Floating Rate Callable Senior Notes due November 2033, and USD 1.25 bn Fixed Rate/Floating Rate Callable Senior Notes due May 2047 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG’s Swiss gone-concern requirement. The Notes are governed by Swiss law and the Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. Homburger advised UBS Group AG with respect to all regulatory and transactional aspects of Swiss law. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Lee Saladino, Daniel Hulmann and Olivier Baum (all Capital Markets), as well as Stefan Oesterhelt (Tax).

On November 4, 2025, CDR-Life and Boehringer Ingelheim announced a new global licensing agreement to develop CDR-Life’s unique antibody-based molecule CDR111 for autoimmune diseases. The agreement builds on the companies’ successful collaboration on an investigational antibody fragment. Under the terms of the agreement, CDR-Life is eligible for up to a total of CHF 456 m in payments, including CHF 38 m in upfront and near-term payments, plus tiered royalties on future sales. Homburger acted as counsel to CDR-Life AG. The Homburger team was led by Luca Dal Molin (IP / IT) and included Richard Stäuber (Regulatory) and Joel Fink (IP / IT). Contact Wanda Schweda / Marketing / [email protected]

Homburger advised Grant Thornton Advisors in its strategic initiative to expand its multinational platform through the acquisitions of Grant Thornton Switzerland and Grant Thornton Liechtenstein. This transaction – together with other recent expansions – creates a team of more than 18,000 professionals in offices stretching from the Americas across Europe and the Middle East to the Asia Pacific region. The transaction was backed by an investor group led by New Mountain Capital. The Homburger team was led by partner Dieter Gericke (Corporate / M&A) and included partners Benjamin Leisinger (Financial Services), Balz Gross (Employment and Executive Compensation) and Richard Stäuber (Competition) as well as associates Thierry Burckhardt, Cédric Berger, Hans Glent Abildgaard, Simone Schmid, Viviane Egli and Leon Indov (all Corporate / M&A), Kimberly Amrein (Employment and Executive Compensation), Giulia Meier (Competition) and Fabrice Eckert (Financial Services). Contact Wanda Schweda / Marketing / [email protected]

On November 20, 2025, Flexion Robotics, a Zurich-based technology company, announced that it had raised USD 50 million in Series A funding from DST Global Partners, NVentures (NVIDIA's venture capital arm), redalpine, Prosus Ventures, and Moonfire. This funding allows Flexion Robotics to expand the Zurich R&D team, scale compute and robot fleets, establish a U.S. presence, and accelerate commercialization of its autonomy stack. The company is already working with major OEM partners, with the ambition to scale these partnerships globally. Homburger advised NVentures. The Homburger team comprised Andreas Müller, Margrit Marti and Lucas Forrer (all Corporate / M&A) as well as specialists. Contact Gloria Pünchera / Marketing / [email protected]

On November 18, 2025, UBS AG, acting through its Stamford branch, successfully completed its issuance of USD 750 m in aggregate principal amount of Floating Rate Senior Notes due 2027 under its medium-term notes program. The notes were offered and sold in reliance on (i) an exemption from registration provided by Section 3(a)(2) of the U.S. Securities Act of 1933, as amended, and (ii) Section 16.6 of Part 16 of the regulations of the Office of the Comptroller of the Currency. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax).

On November 10, 2025, (i) UBS Group AG successfully completed its all-cash tender offers with respect to five series of bail-inable (TLAC) bonds that were originally issued by Credit Suisse Group AG, and (ii) UBS AG, acting through its Stamford branch, successfully completed its all-cash tender offers with respect to two series of senior unsecured notes that were originally issued by Credit Suisse AG, acting through its New York branch. UBS Group AG accepted tenders with respect to four series of such bail-inable (TLAC) bonds in an aggregate principal amount of USD 5.55 bn, and UBS AG, acting through its Stamford branch, accepted tenders in respect of both series of senior unsecured notes in an aggregate principal amount of USD 2.12 bn. The TLAC bonds repurchased by UBS Group AG were eligible to count towards UBS Group AG’s Swiss gone-concern requirement, governed by Swiss law and admitted to trading and listed on the SIX Swiss Exchange, and the notes repurchased by UBS AG, acting through its Stamford branch, were SEC-registered, governed by the laws of the State of New York and not admitted to trading or listed on any regulated trading venue. Homburger advised UBS Group AG and UBS AG with respect to all regulatory and transactional aspects of Swiss law. The Homburger team was led by Benedikt Maurenbrecher and Stefan Kramer and included Olivier Baum and Lee Saladino (all Capital Markets), as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On December 2, 2025, Roche Holdings, Inc. successfully completed its issuance of USD 1.9 bn in aggregate principal amount of senior notes, consisting of USD 500 m 4.075% notes due 2030, USD 600 m 4.374% notes due 2032 and USD 800 m 4.666% notes due 2035. The notes are irrevocably and unconditionally guaranteed by Roche Holding Ltd. The Homburger team was led by Jürg Frick (Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Dieter Grünblatt (Tax). Contact Wanda Schweda / Marketing / [email protected]  

Homburger AG acted as special Swiss counsel to UniCredit Bank GmbH in its capacity as mandated lead arranger in connection with the USD 1.1 bn borrowing base credit facilities. The facility includes an increase option to a total of USD 1.4 bn. UniCredit and ING acted as joint bookrunners and mandated lead arrangers. Sixteen other international syndicate banks are involved in the financing, including Commerzbank, Deutsche Bank, DZ Bank, Helaba, HSBC, LBBW, MUFG, NordLB and Rabobank. As a global coffee wholesaler, Neumann will use the funds to refinance and consolidate its existing financing agreements and to finance the general trading activities of the Neumann Group. Neumann Gruppe GmbH, based in Hamburg, is the holding company of the Neumann Kaffee Group, which comprises more than 40 companies in 28 countries and employs more than 3,300 people worldwide. The Homburger team was led by Daniel Haeberli (Financing) and included Simone Gloor and Céline Rüegg (both Financing) as well as Stefan Oesterhelt (Tax).   Contact Wanda Schweda / Marketing / [email protected]

On December 8, 2025, EQT announced the sale of an additional 10% stake in Galderma Group AG (SIX: GALD) by a consortium led by EQT, which includes Sunshine SwissCo GmbH (SSCO), Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as sellers) to L’Oréal S.A. for an undisclosed amount. Following the transaction, which is subject to customary regulatory approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The EQT-led consortium and L’Oréal agreed to customary provisions for an investment of this type. The previously concluded shareholder undertaking between SSCO and L’Oréal will be dissolved effective upon completion of the transaction. In connection with the increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal. Homburger acted as transaction counsel to EQT. The team was led by Frank Gerhard and Margrit Marti, and comprised Carlo Sulser, Estelle Piccard, Jannis Zafeirakos and Viviane Egli (all Corporate / M&A, Capital Markets), Stefan Oesterhelt and Laetitia Fracheboud (both Tax), Richard Stäuber and Giulia Meier (both Competition) as well as Micha Fankhauser (Financial Market Regulation).

On December 15, 2025, Swixx BioPharma AG announced the signing of an agreement for a strategic investment by SK Capital Partners. The investment values Swixx BioPharma at more than EUR 1.5 bn. Swixx BioPharma is a leading global full-service partner in the distribution of biopharmaceutical products operating across multiple countries in Central and Eastern Europe, Greece, Eurasia and several CIS countries, the Middle East and Latin America. Closing is expected in the second quarter of 2026, subject to customary regulatory approvals. After closing, SK Capital will become Swixx’s lead investor. Biocorp, together with the founders and other shareholders, including Mérieux Equity Partners and HBM Healthcare Investments, will reinvest alongside SK Capital. Homburger is acting as counsel to Biocorp, the founders of Laboratorios Biopas, which was acquired by Swixx BioPharma in summer 2024 and, as part of that transaction, became shareholders in Swixx BioPharma. The Homburger team includes Andreas Müller, Claude Lambert, Hans Glent Abildgaard (all Corporate / M&A) and other subject matter specialists.  

On December 12, 2025, Aris Mining Corporation (TSX: ARIS; NYSEA: ARMN) announced the completion of its acquisition of the remaining 49% interest in the Soto Norte joint venture in Colombia from MDC Industry Holding Company LLC (Mubadala). Aris Mining Corporation now owns 100% of the Soto Norte project, a high-grade, long-life underground gold project that incorporates industry-leading environmental and social design features. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Marco Rostetter (Corporate / M&A) as well as Jürg Frick (Financing).

On December 21, 2025, Windward Bio Group AG, a Swiss-based private, clinical-stage biotechnology company committed to improving outcomes for people living with advanced immunological diseases, announced a licensing agreement between its affiliate, LE2025 Therapeutics AG, and Qyuns Therapeutics Co., Ltd. for the development and commercialization of WIN027 (also known as QX027N), a potential best-in-disease, long-acting bispecific antibody targeting TSLP and IL-13. Under the terms of the agreement, Windward Bio will gain exclusive rights to develop, manufacture, and commercialize WIN027 outside of China, for a total of up to USD 700 m in upfront and equity consideration and development and commercial milestones, as well as tiered royalties. The Homburger team advising Windward Bio includes Andreas Müller, Margrit Marti, Timo Hasler and Lucas Forrer (all Healthcare / Life Sciences and Corporate / M&A), Stefan Oesterhelt and Juliette Buob (both Tax) and other subject matter specialists.     Contact Gloria Pünchera / Marketing / [email protected]  

On 22 October 2025, FalconX and 21Shares announced to join forces by a merger by absorption by FalconX of 21Shares' ultimate parent company. The merger was effected in November 2025. FalconX is a leading digital assets prime brokerage providing comprehensive access to global digital asset liquidity and a full range of services to the world’s top institutions. The firm serves as a single point of access for trading, financing, custody, and direct market access (DMA) across spot, derivatives, and FX markets, supported by advanced technology and sophisticated risk management. 21Shares, through its Swiss offering vehicle 21Shares AG, offers one of the world's largest suite of cryptocurrency exchange-traded products (ETPs), making cryptocurrency investing more accessible. 21Shares will continue to operate as an independent company within the FalconX group, maintaining the same management team and brand. This acquisition strengthens the bridge between listed-market products and the crypto-native ecosystem at a time when digital assets are becoming increasingly institutionalized. Homburger AG advised 21Shares on various Swiss law- and Swiss tax-related matters in the preparation and implementation of the merger. The team was co-led by Margrit Marti (Corporate / M&A) and Benjamin Leisinger (Capital Markets / Financial Market Regulation) and included Stefan Oesterhelt, Reto Heuberger, Peter Müller, Philippe Gobet and Philippe Stiegeler (all Tax), Olivier Bühlmann and Carolina Rodriguez (both Corporate / M&A), Gregor Bühler (Data Protection and Employment), as well as Stefan Bindschedler and Simone Gloor (Financing). Contact Gloria Pünchera / Marketing / [email protected]  

On January 8, 2026, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had signed an exclusive licensing agreement with Nxera Pharma, a biopharmaceutical company listed on the Tokyo Stock Exchange, for the development, manufacturing and commercialization of AGAMREE® for the treatment of Duchenne muscular dystrophy in Japan, South Korea, Australia and New Zealand. Santhera will receive a USD 30 m cash upfront payment and a USD 10 m equity investment through the purchase of c. 530 k shares by Nxera at a 20 % premium to the 30-day VWAP. Homburger advises Santhera on the Swiss corporate, capital markets and financing aspects of the transaction. The Homburger team is led by Daniel Häusermann and includes Marco Rostetter (both Corporate / M&A, Capital Markets) and Eduard De Zordi (Financing, Investment Products, Capital Markets).

On January 13, 2026, Baseline Wealth Management, an established FINMA-registered portfolio manager and SEC-registered investment advisor (RIA) with offices in Geneva and Zurich, announced it has joined Creative Planning, one of the largest RIAs in the United States. The transaction represents Creative Planning’s first international acquisition and underscores the attractivity of Baseline's experience serving international and U.S. clients. The acquisition adds more than USD 1 bn in assets under management to Creative Planning. The Homburger team was led by Frank Gerhard (Corporate / M&A) and included Romain Hondius, Thomas Romelli and Constantin Khovrin (all Corporate / M&A), Alexander Wherlock (Financial Market Regulation) and Philippe Weber (Tax).   Contact Gloria Pünchera / Marketing / [email protected]  

On January 13, 2026, UBS Group AG successfully completed its issuance of EUR 1.5 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due February 2031 and EUR 1.5 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due January 2037 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG’s Swiss gone concern capital requirement. The Notes are governed by Swiss law, and the Notes have been provisionally admitted to trading, and application will be made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino, Olivier Baum and Daniel Hulmann (all Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

January 23, 2026 Homburger acted as Swiss counsel to Fastned Tico Holding I B.V., a direct subsidiary of Fastned B.V., in its capacity as borrower in connection with a Dutch law-governed EUR 100 m committed senior multicurrency term facility agreement with an additional EUR 100 m option with a European lending syndicate consisting of ABN AMRO Bank N.V., Crédit Agricole Corporate and Investment Bank, ING Bank N.V., Invest-NL Capital N.V. and Coöperatieve Rabobank U.A. Fastned B.V. is a Europe-wide operator of electric fast-charging stations and listed at Euronext Amsterdam. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Jürg Frick (Financing), Jonas Stähli and Matthias Müller (both Corporate / M&A), Stefan Oesterhelt, Reto Heuberger and Laetitia Fracheboud (all Tax) as well as Gregor Bühler (IP/IT).     Contact Wanda Schweda / Marketing / [email protected]  

On January 26, 2026, Zürcher Kantonalbank successfully completed its issuance of EUR 500 m 2.950 per cent. Fixed Rate Bonds due January 26, 2031 (the Bonds). The senior unsecured Bonds have been issued under Zürcher Kantonalbank’s Swiss base prospectus consisting of the applicable summary and securities note for the issue of bonds and short term notes of Zürcher Kantonalbank dated June 20, 2025 and the registration form for debt securities dated June 20, 2025, as updated, approved by SIX Exchange Regulation AG and final terms issued thereunder. BNP PARIBAS, Deutsche Bank Aktiengesellschaft, UBS AG London Branch, and Zürcher Kantonalbank acted as the Joint Lead Managers. Homburger acted as counsel to Zürcher Kantonalbank as issuer. The Homburger team was led by Benjamin Leisinger and included Yulia Shaburnykova (both Capital Markets). Tax aspects were covered by Dieter Grünblatt.

On January 15, 2026, UBS Switzerland AG successfully completed its issuance of CHF 150 m 0.435 per cent. Fixed Rate Covered Bonds due January 15, 2029, CHF 190 m 0.745 per cent. Fixed Rate Covered Bonds due January 15, 2032, and CHF 345 m 1.0225 per cent. Fixed Rate Covered Bonds due January 15, 2036, under its Covered Bond Programme. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG’s domestic mortgage pool. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Daniel Hulmann, Yulia Shaburnykova (all Capital Markets), as well as Stefan Oesterhelt (Tax).

On January 27, 2026, SubjectWell, Inc. announced the acquisition of Swiss-based Clariness AG and the merger of Clariness and SubjectWell to form one of the largest global, full-service patient recruitment platforms, combining global scale, scientific rigor, and patient-first design to transform clinical trial access and execution worldwide. Homburger acted as transaction counsel to the selling shareholders. The Homburger team comprised Andreas Müller, Carlo Sulser, Marco Rostetter, Anina Preusker, and Viviane Egli (all M&A), Reto Heuberger and Philippe Weber (both Tax), Luca Dal Molin and Joel Fink (both IP / IT and Healthcare / Life Sciences), and Richard Stäuber, Allegra Arnold, and Timothy Porter (all Competition).

Homburger successfully represented U.S. artistic gymnast Jordan Chiles in proceedings before the Swiss Federal Supreme Court in connection with the 2024 Olympic Games. On January 23, 2026, the Swiss Federal Supreme Court upheld a request for revision filed on behalf of Ms. Chiles and set aside a Court of Arbitration for Sport (CAS) award that had deprived her of the Olympic bronze medal in the women’s gymnastics floor exercise final. Ms. Chiles had initially been awarded the bronze medal after her coach’s inquiry resulted in an increase to her final score. A CAS panel subsequently ruled, however, that the inquiry had been submitted four seconds after the applicable one-minute time limit and was therefore invalid. In September 2024, Homburger filed both a request for revision and an appeal with the Swiss Federal Supreme Court on behalf of Ms. Chiles. In the revision proceedings, Ms. Chiles relied on newly emerged video evidence demonstrating that the inquiry had in fact been submitted within the prescribed time limit. The Swiss Federal Supreme Court granted the request for revision, set aside the CAS award and remitted the matter to the arbitral tribunal. In doing so, it gave particular weight to the extreme time pressure to which Ms. Chiles had been subjected as a result of a gross notification error by the CAS. The belated notification left her with only hours before the issuance of the award to appoint counsel, review the case file, develop a defense strategy, draft a written submission and prepare for a hearing. «The Swiss Federal Supreme Court’s decision underscores the importance of standing firm when fairness is at stake,» the Homburger team representing Ms. Chiles said. The decision constitutes a landmark ruling in several respects, including regarding the requirements for the revision of an arbitral award under the recently revised Swiss arbitration legislation, as well as the conduct of hyper-expedited arbitration proceedings more generally. The Homburger team advising Ms. Chiles was led by Gabrielle Nater-Bass and included Stefanie Pfisterer, Richard G. Allemann and Frédéric Fitzi (all Arbitration, Litigation). Homburger acted as co-counsel together with international counsel Gibson, Dunn & Crutcher LLP.  

On February 2, 2026, OC Oerlikon announced that it has completed the divestment of its Barmag textile machinery business for manmade fibers to Rieter at an enterprise value of CHF 850 m with an earn-out of up to CHF 100 m. With the closing of this transaction, Oerlikon becomes a pure-play surface technology company, serving a broad base of customers in demanding industries – from automotive, aerospace and energy to luxury, medical, defense and semiconductors – with a toolbox of high-tech surface technologies. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Anna Peter, Nicola Togni, Matthias Müller, Alessandro Samà and Fabio Gasser (all Corporate / M&A), Dieter Grünblatt (Tax), Richard Stäuber and Nicolas Stocker (both Competition), Lorenzo Togni (Capital Markets) as well as Jürg Frick (Financing).

On 10 February 2026, Alphabet Inc., the parent company of Google LLC, successfully placed bonds in Switzerland in the aggregate amount of CHF 3.055 bn. The CHF offering was comprised of CHF 905 m aggregate principal amount of 0.4270% senior notes due 2029, CHF 700 m aggregate principal amount of 0.8900% senior notes due 2032, CHF 575 m aggregate principal amount of 1.2525% senior notes due 2036, CHF 455 m aggregate principal amount of 1.5823% senior notes due 2041, and CHF 420 m aggregate principal amount of 1.8675% senior notes due 2051. BNP PARIBAS, Paris, Lancy/Geneva Branch is acting as representative of the initial purchasers for the CHF offering, which include Deutsche Bank AG, London Branch, Goldman Sachs International, J.P. Morgan Securities plc, and Merrill Lynch International. The CHF offering is scheduled to close on or around March 3, 2026, subject to customary closing conditions. The Homburger team consists of Benjamin Leisinger and Eduard de Zordi.

Homburger is advising Transocean Ltd (NYSE: RIG), a leading international provider of offshore contract drilling services for oil and gas wells, on Swiss law matters in connection with its pending acquisition of Valaris Limited (NYSE: VAL), an industry leader in offshore drilling services across all water depths and geographies. On February 9, 2026, Transocean and Valaris announced the signing of a definitive agreement to combine the two companies under which Transocean will acquire Valaris in an all-stock transaction valued at approximately USD 5.8 bn. The enterprise value of the pro forma company is approximately USD 17 bn. The transaction brings together highly complementary, premium offshore assets. On a pro forma basis, the company will own 73 rigs able to serve customers in deepwater, harsh environment, and shallow water basins around the world. Under the terms of the all-stock transaction, Valaris shareholders will receive a fixed exchange ratio of 15.235 shares of Transocean stock for each common share of Valaris. Upon completion and on a fully diluted basis, Transocean shareholders will own approximately 53% of the combined company, with Valaris shareholders owning the remaining 47%. The transaction will be carried out by way of a court-approved scheme of arrangement under Bermuda law and is expected to close in the second half of 2026, subject to regulatory approvals and customary closing conditions, and approvals by the shareholders of each company. The Homburger team advising Transocean was led by David Oser, Micha Fankhauser and Kaiyan Yeo (all Corporate / M&A) as well as Reto Heuberger (Tax).

On February 10, 2026, UBS Group AG successfully completed its issuance of (i) USD 2 bn in aggregate principal amount of Fixed Rate/Floating Rate Callable Senior Notes due April 2030, (ii) USD 1.5 bn in aggregate principal amount of Fixed Rate/Floating Rate Callable Senior Notes due August 2037, (iii) USD 1.25 bn in aggregate principal amount of Fixed Rate/Floating Rate Callable Senior Notes due August 2032, and (iv) USD 500 m in aggregate principal amount of Floating Rate Callable Senior Notes due April 2030 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern capital requirement. The Notes are governed by Swiss law, and the Notes have been provisionally admitted to trading, and application will be made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. Homburger advised UBS Group AG with respect to all regulatory and transactional aspects of Swiss law. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Lee Saladino and Daniel Hulmann (both Capital Markets), as well as Stefan Oesterhelt (Tax).

On February 13, 2026, UBS Group AG successfully completed its offering of AUD 1 bn in aggregate principal amount of 7.125 per cent. Tier 1 Capital Notes. The Notes are "high trigger" regulatory capital instruments that are eligible to fulfill UBS Group AG’s Swiss going concern requirements. Upon occurrence of a "Trigger Event" or a "Viability Event", the Notes will be converted into ordinary shares of UBS Group AG in accordance with their terms. The Notes are governed by Swiss law and have been provisionally admitted to trading on the SIX Swiss Exchange. Application will be made for definitive admission to trading and listing of the Notes on the SIX Swiss Exchange. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Olivier Baum (both Capital Markets) as well as Stefan Oesterhelt (Tax).     Contact Gloria Pünchera/ Marketing / [email protected]

On February 19, 2026, Solabia Group announced that it has entered into an agreement to acquire the Mibelle Biochemistry Business from Persán, a multinational European market leader in home and personal care. The Mibelle Biochemistry Business, part of the Mibelle Group, is a Swiss innovator specializing in the development and production of high‑performance active ingredients for the cosmetics, nutraceutical and food industries. The transaction is expected to close in the first half of 2026, subject to the satisfaction of customary closing conditions. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Carlo Sulser, Cédric Berger, Anina Preusker and Viviane Egli (all Corporate / M&A), Olivier Bühlmann (Real Estate), Gregor Bühler, Joel Fink and Berem Brun (all IP / IT), Angela Casey (Employment and Executive Compensation), Reto Heuberger and Juliette Buob (both Tax) as well as Richard Stäuber and Nicolas Stocker (both Competition).   Contact Wanda Schweda / Marketing / [email protected]

On February 2, 2026, Element Solutions Inc (NYSE: ESI), a global and diversified specialty chemicals technology company, announced that it has completed its previously announced acquisition of Micromax from Celanese Corporation (NYSE: CE) for approximately USD 500 m in cash. Micromax is a leading global supplier of advanced electronic inks and pastes designed for high‑performance electronics and known for their durability, flexibility and performance in harsh environments. The Homburger team advising Element Solutions on all Swiss law aspects of the transaction comprised Andreas Müller and Caspar Wehrle (both Corporate / M&A), Angela Casey (Employment and Executive Compensation), Philippe Gobet, Miriam Kämpf and Philippe Weber (all Tax) as well as Luca Dal Molin (Data Protection). Contact Wanda Schweda / Marketing / [email protected]

On February 18, 2026, UBS Switzerland AG successfully completed its issuance of EUR 750 m 2.5595 per cent. Fixed Rate Covered Bonds due August 18, 2029 and EUR 750 m 3.012 per cent. Fixed Rate Covered Bonds due February 18, 2033 under its Covered Bond Programme. The Covered Bonds are governed by Swiss law and are listed on SIX Swiss Exchange. The Covered Bonds are indirectly backed by a portfolio of mortgages from UBS Switzerland AG’s domestic mortgage pool. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Daniel Hulmann and Yulia Shaburnykova (all Capital Markets), as well as Stefan Oesterhelt (Tax).   Contact Wanda Schweda / Marketing / [email protected]

On March 2, 2026, Zurich Insurance Group Ltd (SIX: ZURN) announced its recommended all-cash offer for the entire issued and to be issued share capital of Beazley plc (Beazley). The transaction combines two highly complementary businesses, accelerating Zurich’s strategy to create the global leader in Specialty insurance. It is intended that the cash consideration for the Beazley shares will be satisfied by applying drawings from the new debt facilities, alongside existing cash resources and proceeds from Zurich Insurance Group Ltd’s recent equity raise. Homburger advised Zurich with respect to all Swiss law aspects of this new debt financing. The Homburger team was led by Stefan Bindschedler (Financing) and Hansjürg Appenzeller (Corporate / M&A, Insurance) and included Fabrice Eckert (Insurance, Financing) and Matthias Müller (Corporate / M&A). Dieter Grünblatt and Arbnor Sheholli provided tax advice.   Contact Wanda Schweda / Marketing / [email protected]

On March 2, 2026, Zurich Insurance Group Ltd (SIX: ZURN) announced the launch of an accelerated bookbuilding offering, which led to the successful placement of 7,090,909 newly issued shares at an offer price of CHF 550 per offered share, raising aggregate gross proceeds of approximately CHF 3.9 bn. Zurich intends to use the net proceeds from the capital increase to partly finance the acquisition of Beazley plc. The offering was conducted by way of (i) a placement to professional investors in Switzerland or in any other circumstances relying on an exemption from the obligation to publish a prospectus under the Swiss Financial Services Act, (ii) private placements in certain jurisdictions outside of Switzerland and the United States, and (iii) private placements within the United States to qualified institutional buyers in reliance on Rule 144A under the U.S. Securities Act. Goldman Sachs, Morgan Stanley and UBS acted as Joint Global Coordinators and Bookrunners, Citigroup and Deutsche Bank acted as Joint Bookrunners as well, and Crédit Agricole and Zürcher Kantonalbank acted as Co-Lead Managers in connection with the offering. Homburger advised Zurich on all aspects of Swiss corporate and capital markets law. The Homburger team was led by Hansjürg Appenzeller (Corporate / M&A, Capital Markets, Insurance) and Lorenzo Togni (Capital Markets) and included Matthias Müller (Corporate / M&A) as well as Fabrice Eckert (Insurance, Financing). Dieter Grünblatt and Arbnor Sheholli provided tax advice. Contact Wanda Schweda / Marketing / [email protected]

On February 18, 2026, the State of North Rhine-Westphalia successfully completed its issuance of (i) CHF 100 m in aggregate principal amount of 0.3675 per cent. State Treasury Notes due February 18, 2031, (ii) CHF 175 m in aggregate principal amount of 0.7700 per cent. State Treasury Notes due February 18, 2036, and (iii) CHF 190 m in aggregate principal amount of 1.0650 per cent.  State Treasury Notes due February 18, 2044 under its Debt Issuance Programme. The State Treasury Notes are governed by German law, and the State Treasury Notes have been provisionally admitted to trading, and application has been made for definitive admission to trading and listing of the Notes, on the SIX Swiss Exchange. Homburger advised Raiffeisen Schweiz Genossenschaft with respect to all regulatory and transactional aspects of Swiss law. The Homburger team was led by Benjamin Leisinger (Capital Markets) and included Sofiya Shavlak (Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On February 23, 2026, ADC Therapeutics SA (NYSE: ADCT) announced that it had amended its royalty purchase agreement with entities managed by HealthCare Royalty. As consideration for reducing change of control payment from USD 750 m to USD 150 m to USD 200 m, HealthCare Royalty has received warrants to purchase approximately 9.8 m common shares of ADC Therapeutics at an exercise price of USD 3.81 per share. Homburger advised ADC Therapeutics on the Swiss law aspects of the transaction. The Homburger team was led by Daniel Häusermann and included Estelle Piccard and Anina Preusker (all Corporate / M&A, Capital Markets).     Contact Wanda Schweda / Marketing / [email protected]

On March 10, 2026, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of ca. 34 m shares in Galderma Group AG corresponding to ca. 14.3% of its share capital at a price of CHF 143.75 per share (the Placement), raising ca. CHF 4.9 bn in total. Following the Placement, the Selling Shareholders have fully exited their investment in Galderma. The Placement thus marks the conclusion of a journey that began with the Selling Shareholders’ acquisition of Galderma in 2019, followed by the Company’s landmark 2024 IPO on SIX Swiss Exchange and continued through a series of successful post IPO sell downs in 2024, 2025 and 2026. Thus, including the IPO, the seven sell-downs in the market by way of accelerated bookbuildings and the two transactions with L’Oréal, the Selling Shareholders have sold Galderma shares for a total amount of ca. CHF 19 bn. As communicated by Galderma on December 8, 2025 in the context of the increased equity investment from L’Oréal, the board members representing the consortium led by EQT will not stand for re-election at the 2026 Annual General Meeting. The Placement is expected to be settled on March 13, 2026. Citigroup Global Markets Limited, Goldman Sachs International, Jefferies GmbH, J.P. Morgan Securities plc, Morgan Stanley & Co. International plc and UBS AG are acting as Joint Global Coordinators and Joint Bookrunners in the Placement. Homburger acted as transaction counsel to EQT. The Homburger team was led by Frank Gerhard and Margrit Marti and included Estelle Piccard and Luca Yousef (all Corporate / M&A, Capital Markets). Contact Wanda Schweda / Marketing / [email protected]

On March 2, 2026, Novartis AG (SIX: NOVN / NYSE: NVS), acting through one of its wholly-owned indirect subsidiaries, completed the acquisition of Avidity Biosciences, Inc. (NASDAQ: RNAM), pursuant to the terms of the merger agreement for a total value of approximately USD 12 bn. Homburger advised Novartis AG and its subsidiaries with respect to all Swiss law aspects of the acquisition of Avidity Biosciences, Inc. The Homburger team was led by Frank Gerhard (Corporate / M&A) and Benjamin Leisinger (Capital Markets) and included Stefan Bindschedler (Financing), Olivier Baum (Capital Markets, Corporate / M&A) as well as Timo Hasler (Corporate / M&A). Contact Wanda Schweda / Marketing / [email protected]

On April 10, 2026, Mondelēz International, Inc., successfully placed bonds in Switzerland in the aggregate amount of CHF 850 m. The CHF offering was comprised of CHF 325 m aggregate principal amount of 0.9575% senior notes due 2029, CHF 245 m aggregate principal amount of 1.2713% senior notes due 2032 and CHF 280 m aggregate principal amount of 1.6250% senior notes due 2036. Deutsche Bank AG London Branch, acting through Deutsche Bank AG Zurich Branch, is acting as representative of the managers for the CHF offering, which include BNP PARIBAS, Paris, Lancy/Geneva Branch, Goldman Sachs International and Commerzbank Aktiengesellschaft. The Homburger team was led by Benjamin Leisinger and Eduard de Zordi (both Capital Markets).   Contact Wanda Schweda / Marketing / [email protected]

On February 23, 2026, Health & Wellness Partners (HWP Group), a leading medical communications and strategic partner to the life sciences industry, has announced the acquisition of Global Market Access Solutions (GMAS), a market access and health economics consultancy with global operations. The Homburger team advising HWP Group comprised Andreas Müller, Carlo Sulser, Magdalena Stock and Fabia Starkermann (all Corporate / M&A), Luca Dal Molin, Angelika Krull and Noëmie Beck-Schär (all IP / IT), Angela Casey (Employment and Executive Compensation) and Laetitia Fracheboud (Tax). Contact Wanda Schweda / Marketing / [email protected]

On May 1, 2026, Siegfried Holding AG, a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, closed the acquisition of three drug substances sites in the US and Australia from an affiliate of SK Capital Partners. Homburger acted as counsel to Siegfried Holding AG in connection with a Swiss law-governed bridge term facility agreement with UBS Switzerland AG as mandated lead arranger and lender. The Homburger team was led by Jürg Frick (Financing) and included Stefan Bindschedler (Financing) as well as Stefan Oesterhelt (Tax).

On March 18, 2026, Nestlé Capital Corporation successfully completed its issuance of (i) USD 750 m in aggregate principal amount of 4.200% Notes due 2031, (ii) USD 500 m in aggregate principal amount of 4.500% Notes due 2033, and (iii) USD 750 m in aggregate principal amount of 4.800% Notes due 2036. The Notes are guaranteed by the Nestlé group’s Swiss parent company Nestlé S.A. The offering of the Notes was done in reliance on Rule 144A and Regulation S under the U.S. Securities Act. Homburger advised Nestlé on all Swiss law aspects of the transaction. The Homburger team was led by Lee Saladino (Capital Markets) and included Daniel Daeniker (Corporate / M&A) and Dieter Grünblatt (Tax).   Contact Wanda Schweda / Marketing / [email protected]

On May 4, 2026, 908 Devices Inc. (NASDAQ: MASS) announced the completion of its acquisition of Swiss-based NIRLAB SA for a combination of cash and stock, including earn-out consideration. The NIRLAB Group develops near-infrared (NIR) spectroscopy solutions for instant material identification. 908 Devices is revolutionizing chemical analysis with its simple handheld devices for vital health, safety, and defense tech applications, such as the illicit drug crisis, toxic carcinogen exposure, and global security threats. The Homburger team advising 908 Devices Inc. comprised Andreas Müller, Olivier Bühlmann, Carlo Sulser, Luca Yousef, Fabia Starkermann and Géraldine Bär (all Corporate / M&A), Luca Dal Molin and Berem Brun (both IP / IT), Reto Heuberger and Juliette Buob (both Tax), Angela Casey (Employment and Executive Compensation), and Richard Stäuber, Allegra Arnold and Giulia Meier (all Competition).   Contact Nanding Susso / Marketing / [email protected]

Homburger advised funds managed by Apollo Capital Management L.P. (Apollo Funds) on their strategic minority investment into vVARDIS Holding AG, a high-growth Swiss dental medtech company focused on non-invasive treatment solutions. The investment from Apollo Funds will support vVARDIS’ continued international expansion and the further development and commercialization of its product portfolio, building on prior funding that has accelerated the global rollout of its technologies. vVARDIS announced the investment alongside achieving unicorn status, marking a significant milestone in the company’s growth trajectory and underscoring strong investor confidence in its innovative technology and global expansion strategy. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Margrit Marti, Anna Peter, Marco Rostetter and Jonas Stähli (all Corporate / M&A) as well as Gregor Bühler and Vanessa Huber (both IP / IT).   Contact Nanding Susso / Marketing / [email protected]

On March 23, 2026, Swiss-based Kandou AI, a leader in high-speed, energy-efficient connectivity and system solutions for the AI era, announced the successful closing of its USD 225 m strategic funding round with backing from strong financial and strategic investors. The oversubscribed Series-A round was led by Maverick Silicon with strategic participation from SoftBank Group Corp., Synopsys, Inc., Cadence Design Systems, Inc. and Alchip Technologies Limited; several existing investors also participated in the financing round. The Homburger team advising Kandou AI on all aspects of this transaction comprised Andreas Müller, Anna Peter, Luca Ellenberger, Oriana Schöni, Luca Yousef and Filippo Moggi (all Corporate / M&A), Stefan Oesterhelt and Juliette Buob (both Tax), Stefan Bindschedler, Alexander Wherlock and Sara D’Antoni (all Financing), Luca Dal Molin and Joel Fink (both IP/IT, Data Protection) as well as Angela Casey (Employment and Executive Compensation). Contact Wanda Schweda / Marketing / [email protected]

On April 16, 2026, EFG International Finance (Luxembourg) S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of Luxembourg, issued EUR 500 m 3.925% Guaranteed Bonds 2026 – 2031. The bonds are guaranteed by EFG International AG. The bonds and the guarantee as well as the transaction agreements are governed by Swiss law. UBS AG, London Branch, BofA Securities Europe SA and J.P. Morgan Securities plc acted as Joint Lead Managers. The Homburger team was led by Benjamin Leisinger and Eduard de Zordi (both Capital Markets). Contact Wanda Schweda / Marketing / [email protected]

On March 25, 2026, Liechtensteinisches Pfandbriefinstitut AG established a program for the issuance of Liechtensteiner Pfandbriefe issued by Liechtensteinisches Pfandbriefinstitut AG, with UBS AG, LGT Bank AG and Liechtensteinische Landesbank AG acting as dealers under the program. The Liechtensteiner Pfandbriefe issued under the program will be indirectly backed by a portfolio of mortgages in accordance with the Liechtenstein Pfandbrief Act. On April 24, 2026, Liechtensteinisches Pfandbriefinstitut AG completed its inaugural issuance of Liechtensteiner Pfandbriefe under the program in an aggregate principal amount of CHF 250 m, consisting of CHF 150 m 0.65% Liechtensteiner Pfandbriefe due 2031 and CHF 100 m 0.90% Liechtensteiner Pfandbriefe due 2036. The Liechtensteiner Pfandbriefe are governed by Swiss law, have been assigned a ʻAaaʼ rating by Moody’s and will be listed on the SIX Swiss Exchange. UBS AG acted as Sole Bookrunner and Joint Lead Manager and LGT Bank AG and Liechtensteinische Landesbank AG acted as Joint Lead Managers. The Homburger team was led by Stefan Kramer (Capital Markets) and included Daniel Hulmann, Olivier Baum and Yulia Shaburnykova (all Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On March 16, 2026, UBS AG, acting through its Stamford branch, successfully completed its issuance of (i) USD 500 m in aggregate principal amount of Floating Rate Senior Notes due 2029, (ii) USD 1.3 bn in aggregate principal amount of 4.302 per cent.  Senior Notes due 2029 and (iii) USD 1.25 bn in aggregate principal amount of 4.632 per cent. Senior Notes due 2032 under its medium-term notes program. The notes were offered and sold in reliance on (i) an exemption from registration provided by Section 3(a)(2) of the U.S. Securities Act of 1933, as amended, and (ii) Section 16.6 of Part 16 of the regulations of the Office of the Comptroller of the Currency. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Lee Saladino and Daniel Hulmann (all Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On March 31, 2026, Marriott International (Nasdaq: MAR) and the Leali family, founders of Lefay, announced their plans to enter into a joint venture to bring the highly awarded luxury wellness hospitality brand Lefay into the Marriott portfolio. Completion of the transaction is subject to customary approvals and closing conditions. Lefay will be the first brand in Marriott’s portfolio dedicated exclusively to luxury wellness. The Lefay portfolio includes two award-winning luxury resorts in Italy (Lago di Garda and Dolomiti), and a further three properties are under development in Tuscany, Southern Italy, and the Swiss Alps. The Homburger team advising Marriott on all Swiss law aspects of the transaction comprises Margrit Marti, Tobias Gloor and Florian Gasche (all Corporate / M&A) as well as Reto Heuberger, Arbnor Sheholli and Alessandra Dumitru (all Tax). Contact Wanda Schweda / Marketing / [email protected]

Homburger acted as counsel to UBS Switzerland AG in its capacity as Coordinating Bookrunning Mandated Lead Arranger, Original Lender and Agent in connection with BACHEM HOLDING AG’s new CHF 500 m revolving credit facility agreement. Homburger advised UBS Switzerland AG as well as the other syndicate banks with regard to all legal aspects of the financing transaction. The Homburger team was led by Daniel Haeberli and Stefan Bindschedler (both Financing) and included Yulia Shaburnykova (Financing) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On May 18, 2026, Zürcher Kantonalbank successfully completed its issuance of EUR 500 m 3.080 per cent. Fixed Rate Bonds due May 18, 2029 (the Bonds). The senior unsecured Bonds have been issued under Zürcher Kantonalbank’s Swiss base prospectus consisting of the applicable summary and securities note of Zürcher Kantonalbank each dated June 20, 2025 and the registration form for debt securities dated June 20, 2025, as amended, approved by SIX Exchange Regulation AG and final terms issued thereunder. BNP PARIBAS, Commerzbank Aktiengesellschaft, UBS AG London Branch, and Zürcher Kantonalbank acted as the Joint Lead Managers. Homburger acted as counsel to Zürcher Kantonalbank as issuer. The Homburger team was led by Benjamin Leisinger and included Sofiya Shavlak (both Capital Markets). Tax aspects were covered by Dieter Grünblatt. Contact Wanda Schweda / Marketing / [email protected]

On May 13, 2026, Novartis Finance S.A. successfully completed its issuance of EUR 600 m 3.100 per cent.  Fixed Rate Notes due January 13, 2032, EUR 600 m 3.500 per cent. Fixed Rate Notes due May 13, 2035 and EUR 500 m 4.000 per cent. Fixed Rate Notes due May 13, 2041. The Notes are unconditionally and irrevocably guaranteed by Novartis AG. The Homburger team was led by Benjamin Leisinger (Capital Markets) and Frank Gerhard (Corporate/M&A, Capital Markets) and included Eduard De Zordi (Capital Markets), Daniel Junginger and Yulia Shaburnykova (both Capital Markets, Financing) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On May 4, 2026, Windward Bio Group AG, a private, clinical-stage biotechnology company committed to improving outcomes for people living with serious immunological diseases, announced an upsized USD 165 m crossover financing led by OrbiMed, with participation from existing Series A investors including Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital, and Pivotal bioVenture Partners. The financing also included new investors RA Capital Management, Janus Henderson Investors, Sanofi Ventures, and Harbour BioMed. The Homburger team advising Windward Bio includes Andreas Müller, Margrit Marti, Lucas Forrer, Anina Preusker and Géraldine Bär (all Corporate / M&A) as well as Stefan Oesterhelt and Juliette Buob (both Tax). Contact Nanding Susso / Marketing / [email protected]

On April 8, 2026, Landis+Gyr Group AG, a global energy technology leader driving intelligent innovation across the grid, announced the successful completion of the divestiture of its Europe, Middle East and Africa (EMEA) business to AURELIUS, a global private equity investor.  The transaction, which was announced in September 2025, has closed with economic effect as of March 31, 2026, following the satisfaction of customary regulatory approvals and closing conditions. As a result of the transaction, AURELIUS has acquired Landis+Gyr’s EMEA operations, encompassing the full metering portfolio for residential electricity, ICG electricity, gas, thermal and water, as well as the related integrated software and services solutions, together with five production sites and approximately 2,800 employees across the region. The Homburger team is led by Daniel Hasler (Corporate / M&A) and includes Anna Peter, Patrick Schmidt, Nicola Togni, Luc Huber and Fabia Starkermann (all Corporate / M&A), Gregor Bühler, Philippe Baumann and Joel Fink (all IP / IT), Reto Heuberger, Philippe Weber and Juliette Buob (all Tax), Peter Müller (Pension), Richard Stäuber (Competition), as well as Jürg Frick and Stefan Bindschedler (both Financing). Contact Johanna Schmid / Marketing / [email protected]

Homburger acted as counsel to Bank of America, J.P. Morgan and UBS Switzerland AG as bookrunners, mandated lead arrangers and coordinators and to UBS Switzerland AG as agent and security agent in connection with the refinancing of SHL Medical AG. Headquartered in Switzerland, SHL is a world-leading provider of drug delivery solutions such as autoinjectors and serves as a partner to global pharmaceutical companies and biotech firms. Homburger advised Bank of America, J.P. Morgan and UBS Switzerland AG and all other syndicate banks with regard to all Swiss legal aspects of the refinancing transaction. The Homburger team was led by Stefan Bindschedler and Jürg Frick (both Financing) and included Olivier Baum (Capital Markets) and Sofiya Shavlak (Capital Markets, Financing) as well as Stefan Oesterhelt (Tax).   Contact Johanna Schmid / Marketing / [email protected]

On April 8, 2026, UBS, PostFinance, Sygnum, Raiffeisen, Zürcher Kantonalbank, BCV and Swiss Stablecoin AG announced the launch of a joint CHF stablecoin sandbox. The new initiative will test potential use cases for a CHF stablecoin in Switzerland. In doing so, the partners are exploring ways to connect blockchain applications with the Swiss franc, aiming to strengthen both the Swiss digital money ecosystem and the competitiveness of Switzerland’s financial center. Homburger advised UBS, PostFinance and Sygnum with regard to contractual, corporate, regulatory and other legal aspects of the sandbox. The Homburger team was led by Dieter Gericke (Corporate / M&A) and Stefan Kramer (Financial Market Regulation / Investment Products) and included Daniel Bötticher and Constantin Khovrin (both Corporate / M&A) as well as Allegra Arnold (Competition) and Luca Dal Molin (IP / IT).   Contact Beatrice Winkler / Marketing / [email protected]

On May 20, 2026, Raiffeisen Schweiz Genossenschaft successfully placed its inaugural digital bail-in bond on the Swiss capital market. The bond will be traded on the SIX Swiss Exchange. The issued digital bail-in bond has the same legal status and the same rating as a traditional bail-in bond issued by Raiffeisen Schweiz Genossenschaft. Raiffeisen Schweiz Genossenschaft acted as lead manager for this transaction. The Homburger team was led by Benjamin Leisinger (Capital Markets, Financial Market Regulation) and included Sofiya Shavlak (Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On March 26, 2026, UBS AG, acting through its Stamford branch, successfully established a U.S. commercial paper program. The notes to be issued under the program will be offered pursuant to an exemption from registration under Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the «Securities Act»). The notes to be issued under the program will also be exempt from the registration requirements of the Securities Act pursuant to Section 3(a)(2) of the Securities Act and will be offered and sold pursuant to the exemption set forth in Section 16.5(b) of the securities offering regulations of the Office of the Comptroller of the Currency. Homburger advised UBS AG with respect to all transactional aspects of Swiss law. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher (both Capital Markets) and included Lee Saladino and Daniel Hulmann (both Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On May 26, 2026, Eli Lilly and Company (NYSE: LLY) announced the acquisition of LimmaTech Biologics AG for up to USD 780 m in cash, inclusive of an upfront payment and additional potential payments based upon the achievement of certain clinical and regulatory milestones. LimmaTech Biologics is developing vaccines against bacterial pathogens for which rising antimicrobial resistance is steadily closing therapeutic options. The Homburger team advising Eli Lilly includes Anna Peter, Bianca Nedwed, Daniel Kuhn, Jana Waldvogel and Ivo Graf (all Corporate / M&A), Joel Fink (IP / IT), Jeremy Reichlin and Giulia Menegon (both Employment and Executive Compensation) as well as Stefan Oesterhelt and Juliette Buob (both Tax).     Contact Wanda Schweda / Marketing / [email protected]

On May 28, 2026, Amazon.com, Inc. issued bonds in Switzerland in the aggregate amount of CHF 2.82 bn. The CHF offering was comprised of CHF 900 m aggregate principal amount of 0.8350% notes due 2029, CHF 585 m aggregate principal amount of 1.200% notes due 2032, CHF 475 m aggregate principal amount of 1.4475% notes due 2035, CHF 390 m aggregate principal amount of 1.6750% notes due 2038, CHF 245 m aggregate principal amount of 1.9389% notes due 2044 and CHF 225 m aggregate principal amount of 2.0825% notes due 2051. BNP PARIBAS, Paris, Lancy/Geneva Branch is acting as representative of the initial purchasers for the CHF offering, which include Deutsche Bank AG, London Branch, J.P. Morgan Securities plc as Joint Book-Running Managers and eighteen Co-Managers. The Homburger team consists of Benjamin Leisinger, Eduard De Zordi and Olivier Baum. Contact Wanda Schweda / Marketing / [email protected]

On June 3, 2026, PPG Industries, Inc. issued bonds in Switzerland in the aggregate amount of CHF 320 m. The CHF offering was comprised of CHF 180 m aggregate principal amount of 1.2175% notes due 2030 and CHF 140 m aggregate principal amount of 1.6648% notes due 2034. BNP PARIBAS, Paris, Lancy/Geneva Branch acted as Sole Manager. The Homburger team consists of Benedikt Maurenbrecher, Eduard De Zordi and Daniel Hulmann (all Capital Markets).     Contact Wanda Schweda / Marketing / [email protected]

On May 29, 2026, UBS AG, acting through its Stamford branch, successfully completed its issuance of USD 1.5 bn in aggregate principal amount of 4.678% Fixed-to-Floating Rate Senior Notes due 2030 under its medium-term notes program. The notes were offered and sold in reliance on (i) an exemption from registration provided by Section 3(a)(2) of the U.S. Securities Act of 1933, as amended, and (ii) Section 16.6 of Part 16 of the regulations of the Office of the Comptroller of the Currency. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Lee Saladino and Daniel Hulmann (all Capital Markets) as well as Stefan Oesterhelt (Tax). Contact Wanda Schweda / Marketing / [email protected]

On June 8, 2026, Temenos AG (SIX: TEMN), a global leader in banking technology, announced the acquisition of additiv AG, a Swiss fintech company providing a specialist platform to orchestrate financial services. The transaction is subject to customary closing conditions. The consideration will be paid c.50% in cash and c.50% in equity. The Homburger team is led by partners Dieter Gericke and Daniel Häusermann and includes Timo Hasler, Florian Gasche and David Fankhauser (all Corporate / M&A), Gregor Bühler, Philippe Baumann and Vanessa Huber (all IP / IT, Technology and Digital Economy), Stefan Oesterhelt and Juliette Buob (both Tax), Richard Stäuber and Timothy Porter (both Competition, Regulatory) as well as Jeremy Reichlin (Employment / Executive Compensation).     Contact Wanda Schweda / Marketing / [email protected]

On June 1, 2026, UBS AG, acting through its London branch, successfully completed its issuance of EUR 1.25 bn in aggregate principal amount of Fixed Rate/Floating Rate Notes due 2032 under its Euro Note Programme. The Homburger team was led by Stefan Kramer and Benedikt Maurenbrecher and included Lee Saladino and Daniel Hulmann (all Capital Markets) as well as Stefan Oesterhelt (Tax).     Contact Wanda Schweda / Marketing / [email protected]

On June 8, 2026, TGS, a leading global provider of energy data and intelligence, announced its acquisition of Apparition Geoservices GmbH, securing exclusive access to its proprietary simultaneous source acquisition and separation technology. Combined with TGS's Gemini Enhanced Frequency Source (EFS) technology, Apparition creates a platform for step-change improvements in seismic operational efficiency, source capacity and subsurface imaging clarity. The Homburger team advising TGS comprised Margrit Marti, Claudine Schär and Géraldine Bär (all Corporate / M&A), Stefan Oesterhelt and Juliette Buob (both Tax) and Luca Dal Molin (IP / IT). Contact Nanding Susso / Marketing / [email protected]

On June 9, 2026, Idorsia Ltd (SIX: IDIA), a commercial-stage biopharmaceutical company with a portfolio of first- or best-in-class assets, entered into a senior secured term loan agreement of up to CHF 250 million with investment funds managed by Pharmakon Advisors, LP. The first tranche of CHF 150 million will be used, among other things, to refinance existing financing of the Idorsia group, with further tranches available, subject to customary conditions, to support targeted initiatives to accelerate growth and long‑term value creation. Homburger advised Idorsia Ltd on the Swiss law aspects of the transaction. The Homburger team was led by Frank Gerhard and included Eduard De Zordi and Daniel Hulmann (all Capital Markets).   Contact Wanda Schweda / Marketing / [email protected]

On June 17, 2026, Zürcher Kantonalbank (ZKB) successfully completed a further offering of Bail-in Bonds in the amount of EUR 500 m. Zürcher Kantonalbank’s Bail-in Bonds, including the newly placed EUR 500 m 3.622% 6NC5 Bail-in Bonds, have been designed and issued on the basis of a legal framework allowing Cantonal Banks to issue Total-Loss-Absorbing-Capacity (Gone-Concern Capital) Bonds. If FINMA orders the partial or complete reduction of the bondholders’ claims under the Bail-in Bonds, the bondholders are entitled to receive Recovery Certificates. Such Recovery Certificates include claims, subject to multiple conditions precedent, for subsequent future compensation payments for the full or partial reduction of the bondholders’ claims under the Bail-in Bonds.   BNP PARIBAS, Commerzbank Aktiengesellschaft, UBS London Branch and Zürcher Kantonalbank acted as Joint Lead Managers. The team advising Zürcher Kantonalbank as issuer on all Swiss law aspects was led by Benjamin Leisinger (Capital Markets and Financial Market Regulation) and included Sofiya Shavlak and Yulia Shaburnykova (both Capital Markets). Tax aspects were covered by Dieter Grünblatt.   Contact Beatrice Winkler / Marketing / [email protected]